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of effector functions and the ability to mount a rapid, potent secondary response. During a chronic viral
infection, however, the pathogen is not cleared, and this appears to drive antigen-specific CD8 T cells down
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and gene expression studies show that the differentiation of exhausted CD8 T cells may be regulated by a
unique transcriptional program. However, the exact pathways and mechanisms that directly regulate the
differentiation of dysfunctional CD8 T cells during chronic viral infection are not clear. In this work, we
examine transcriptional, homeostatic and ‘inflammatory’ vs. antigenic regulation of functional exhaustion.
Through a system of partial and total conditional deletion, we identify the transcriptional repressor Blimp-1 as
an important regulator of functional exhaustion and repressor of memory differentiation. We also describe a
key memory property defect and the mechanism by which exhausted antigen-specific CD8 T cells are
maintained during chronic infection. Lastly, we show that prolonged, pathogen-induced ‘inflammation’ alone
can alter memory CD8 T cell differentiation, while other signals such as antigen may be necessary to lead to
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understanding of how functional exhaustion may occur during chronic viral infection.
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ABSTRACT 
 
REGULATION OF CD8 T CELL DYSFUNCTION DURING A CHRONIC VIRAL 
INFECTION 
Haina Shin 
E. John Wherry, Ph.D. 
 
 After an acute infection or vaccination, antigen-specific CD8 T cells 
undergo memory differentiation once the pathogen has been completely cleared.  
Memory CD8 T cells acquire cardinal properties that allow them to confer long-
term protection, including antigen-independent homeostasis and self-renewal, 
rapid reacquisition of effector functions and the ability to mount a rapid, potent 
secondary response.  During a chronic viral infection, however, the pathogen is 
not cleared, and this appears to drive antigen-specific CD8 T cells down an 
altered path of differentiation.  During chronic viral infection, antigen-specific CD8 
T cells become functionally exhausted, in which they progressively lose effector 
function and upregulate the expression of multiple inhibitory receptors.  Specific 
memory defects also occur, as exhausted CD8 T cells do not use the IL-7/IL-15 
pathway efficiently.  Antigen load and lack of CD4 help correlate to the severity of 
dysfunction, and gene expression studies show that the differentiation of 
exhausted CD8 T cells may be regulated by a unique transcriptional program.  
However, the exact pathways and mechanisms that directly regulate the 
differentiation of dysfunctional CD8 T cells during chronic viral infection are not 
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clear.  In this work, we examine transcriptional, homeostatic and ‘inflammatory’ 
vs. antigenic regulation of functional exhaustion.  Through a system of partial and 
total conditional deletion, we identify the transcriptional repressor Blimp-1 as an 
important regulator of functional exhaustion and repressor of memory 
differentiation.  We also describe a key memory property defect and the 
mechanism by which exhausted antigen-specific CD8 T cells are maintained 
during chronic infection.  Lastly, we show that prolonged, pathogen-induced 
‘inflammation’ alone can alter memory CD8 T cell differentiation, while other 
signals such as  antigen may be necessary to lead to the loss of effector functon 
and high expression of inhibitory receptors that are hallmarks of functional 
exhaustion.  Together, we have identified multiple pathways at different levels of 
regulation that further our understanding of how functional exhaustion may occur 
during chronic viral infection. 
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Chapter 1 
Introduction 
 
Immunological memory: A (brief) historical perspective. 
 The concept of immunological memory has existed for a long time, 
stretching back over two thousand years to the plague of Athens during the 
Peloponnesian War.  The historian Thucydides noted that in the time of this 
terrible disease, the most effective caregivers were those that had been 
previously infected and recovered, “for the same man was never attacked twice – 
at least not fatally” (1).  About a millennia later, the Chinese and Indians first put 
this concept to practice through a crude form of vaccination known as variolation 
(2).  In an attempt to protect against the scourge of smallpox, material from the 
pustules of infected patients was introduced into healthy individuals, who were 
subsequently protected from disease (2).  Despite the significant morbidity and 
mortality associated with variolation and the occasional epidemics that the 
practice caused, it remained popular until the observations of Edward Jenner (3).  
The birth of modern vaccinology is credited to Jenner, based on experiments that 
showed that innoculation of a milder disease (cowpox) would protect from a more 
severe but related infection (smallpox) (3).  
 Despite this breakthrough in disease prevention, the immunological and 
microbiological basis behind vaccination was unknown.  It was not until the 
establishment of the germ theory of disease and the discovery of multiple 
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microbes that the cause of infection was known (2, 4).  Later, the observation 
that immunity could be passively transferred through sera (antibodies) laid the 
immunological groundwork for the study of vaccines (2).  Although recognition of 
cellular immunity did not occur until well after the discovery of humoral immunity 
(5), the field of immunology was rapidly becoming very effective at combating 
many major public health threats. 
 By 1962, progress in the study of immunology, the ability to develop new 
vaccines and emergence of antibiotics caused the famed virologist and 
immunologist Sir McFarlane Burnet to declare that “…almost all the major 
practical problems of dealing with infectious disease had been solved” and that 
“The late 20th century will be the witness to the virtual elimination of infectious 
disease as a significant factor in social life” (6).  This, however, has not proven to 
be the case.  Rather than seeing the end of infectious disease, the late 20th 
century has been witness to the rise of enormous new problems, including super-
resistant pathogens and the HIV/AIDS pandemic.   
 At present, almost thirty years after the onset of the pandemic, over 33 
million people suffer from HIV/AIDS, with millions more infected each year (7).  
Hundreds of millions suffer from other chronic viral infections such as HCV and 
HBV (8).  While vaccines for HBV exist (8) and antiviral medications for these 
infections are available, their limited efficacy, uneven distribution and expense 
make it imperative to discover vaccination strategies and immunotherapies that 
will help relieve disease burden, particularly in the developing world.  Although 
great advances have been made in understanding the biology and pathogenesis 
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of infections such as HIV (9), all of the immunological determinants that are 
required in order to successfully control these infections have not yet been 
defined.  One parameter that appears to correlate with good viral control is potent 
cytotoxic T cell responses (10-13) .  However, during many human chronic viral 
infections, as well as animal models of chronic viral infection, virus-specific CD8 
T cells often lose their effector function and become functionally exhausted (14).  
The mechanisms that regulate functional exhaustion are not well understood, 
and the studies that lie herein will attempt to elucidate some of the the cell-
intrinsic and –extrinsic factors that regulate the differentiation of dysfunctional T 
cells during chronic viral infection. 
 
An overview of the adaptive immune system. 
 The immune system consists of two major arms – the innate immune 
system, and the adaptive immune system.  Lymphocytes within the adaptive 
immune system each express a unique receptor, and all together they create a 
broad repertoire of specificities (15, 16).  The defining characteristic of the 
adaptive immune system is its ability to use this broad repertoire to ‘adapt’ 
immune responses to individual pathogens by the process of clonal selection (15, 
16).  Another key characteristic of the adaptive immune system is immunological 
memory – the ability to ‘remember’ previous encounters with a particular 
pathogen (17).  The adaptive immune system is primarily composed of two cell 
types: T cells and B cells.  While B cells provide the humoral component of 
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adaptive immunity and are critical for most current vaccines, this study will focus 
on T cells, and specifically, CD8 T cells. 
 T cells, like all leukocytes, are generated from hematopoeitic stem cells 
(HSCs).  HSCs give rise to a number of progenitor cells, including a thymic 
settling progenitor that seeds the thymus and gives rise to an early thymic 
progenitor (18).  Within the thymus, thymocytes go through three distinct phases: 
double negative (CD4-CD8-, DN), double positive (CD4+CD8+, DP)  and single 
positive (CD4+CD8- or CD4-CD8+, SP) (18).  Expression of a functional pre-T 
cell receptor (TCR) by DN thymocytes leads to the DP stage (19), where 
successful V(D)J recombination of the TCRα chain leads to the expression of a 
TCR by DP thymocytes (20).  To pass from the DP to the SP stage, thymocytes 
must successfully go through positive selection, which determines the 
functionality of the TCR by its ability to recognize self-peptide bound to MHC 
class I (CD8 SP) or class II (CD4 SP), and the lineage of the future T cell is 
established (20).  DP thymocytes must also undergo negative selection, a 
process that mediates central tolerance and removes most self-reactive T cells 
from the repertoire (21). 
 Once in the periphery, naïve T cells are maintained by the cytokine IL-7 
and contact with the appropriate self-peptide/MHC complex (22).  Upon infection 
or vaccination, T cells become activated when they encounter a mature antigen-
presenting cell (APC) that carries a pathogen-derived peptide bound to an MHC 
molecule that is recognized by their specific TCR (signal 1).  Costimulatory 
signals (signal 2), such as those received from molecules like CD28, CD27, 
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OX40 and others (23), and a ‘signal 3’ provided by inflammation generally leads 
to a productive T cell response (24-26).  Once activated, the inflammatory 
environment can reinforce the type of response that will occur (27, 28).  Other 
signals, such as those received through toll-like receptors (TLRs) have been 
shown to play a role in the activation and proliferation of T cells (29, 30). 
CD4 and CD8 T cells perform distinct functions during immune responses.  
CD4 T cells, or T helper (Th) cells can determine the type of response that will be 
made to a pathogen.  The heterogeneity within the CD4 T cell population was 
first defined by the cytokines secreted by Th1 (IFNγ and IL-2) and Th2 cells (IL-4 
and IL-5) (31).  Ensuing work with Leishmania major infection showed that the T 
helper subsets could be further distinguished by the ability to protect against or 
exacerbate disease (32).  Subsequently, Th1 responses were designated as 
protective against intracellular pathogens, while Th2 responses were shown to 
be protective against helminths and extracellular pathogens (27).  More recently, 
a novel lineage has joined the T helper paradigm (33-35).  Called Th17 for the 
production of IL-17, this subset plays a an important role in host defense and 
promotes inflammation during autoimmune disorders (36).  These three subsets, 
along with regulatory T cells (Treg), were thought to be distinct, mutually 
exclusive lineages (28).  Th1, Th2, Th17 and Treg cells all express definitive 
transcription factors, and interactions between these transcription factors can 
lead to the repression of other lineages (28).  Furthermore, fully differentiated 
subsets of T helper cells can undergo chromatin remodeling to reinforce gene 
expression and silence genes of other lineages (37).  However, recent studies 
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with Tregs and Th17 cells show that the CD4 T cell lineages may be more plastic 
than originally thought (38).  In addition to the direct response of CD4 T cells 
against pathogens, T helper cells can condition DCs (39-41) and also provide 
help to both B cells (42) and CD8 T cells (43). 
CD8 T cells are cytotoxic lymphocytes (CTLs) that kill infected target cells.  
CD8 T cells can respond to both intracellular and extracellular pathogens as well 
as cancers (44).  CD8 T cells, like CD4 T cells, can differentiate into T cytotoxic 
type I (Tc1) cells, which secrete IFNγ and TNFα, and T cytotoxic type II (Tc2) 
cells, which produce IL-4, IL-5 and IL-10 (44, 45).  Although Tc2 cells have been 
found in situations of chronic infections as well as cancer (46-48), and can be 
generated in vitro (49), their role in the immune response has not been as well 
explored as Tc1.  CTLs are capable of directly lysing infected target cells using 
the cytotoxic granules granzyme and perforin (50), although in some murine 
cancer models Tc2 cells have been shown to be less effective at utilizing this 
pathway (51).  CTLs may also induce apoptosis of target cells through Fas/FasL 
interactions (50).  More recently, it has been shown that CD8 T cells can also 
produce IL-17, with or without genetic manipulation, although some Tc17 cells do 
not appear to have any cytolytic capacity (52-54). 
 Once activated, CD8 T cells undergo a massive clonal burst during which 
naïve precursors differentiate into effector CD8 T cells and increase in number by 
several orders of magnitude (55-57).  For CTLs, the size of the clonal burst can 
be programmed within a very short priming phase (58, 59).  Within the effector 
population, there is heterogeneity that can broadly be defined as cells that will 
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eventually die, and those that will not.  These two subsets are terminally 
differentiated effector CD8 T cells and memory precursors (60, 61).  Both 
subsets are equally cytotoxic have similar effector gene expression patterns, but 
terminally differentiated effector CD8 T cells are characterized by their high 
expression of KLRG-1, low expression of the IL-7Rα chain (CD127), and high 
levels of the transcription factor Tbet, while memory precursors are KLRG-
1lo/int,CD127hi, Tbetlo and can produce high levels of IL-2 (60-63).  Memory 
precursor cells survive and differentiate into a population of long-lived memory 
CD8 T cells (64).  Unlike memory precursors, many terminally differentiated 
effector CD8 T cells are destined to die during or shortly after the contraction 
phase (60, 61), although a small percentage does survive, most likely by IL-15 
signaling (60, 65).  These cells appear form a small pool of ‘terminal’ effector 
memory CD8 T cells with memory properties that are less developed than 
effector memory CD8 T cells that arise from memory precursors (60, 65, 66). 
It is not yet clear how the CD8 T cell effector subsets are generated, and 
there is also some contention as to whether there is a linear differentiation 
relationship between effector and memory CD8 T cells (66-69).  Several models 
have been set forth to explain the how these two subsets are formed, and thus 
far a model of progressive differentiation appears to encompass the current data 
most effectively (66).  In this model, two lineages are formed upon activation 
through differences in TCR signal strength and length of stimulation (60, 61, 70-
72). Asymmetric division has been proposed as a mechanism to initiate 
heterogeneity at the activation stage, where one single cell can give rise to two 
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daughter cells that are of different fates (72).  Although the subsets are formed 
early, they remain plastic as KLRG-1lo cells retain the ability to give rise to KLRG-
1hi cells (60, 61).  The size of each subset is likely determined not only by TCR 
signals, but also by the strength and length of exposure to inflammation (60, 61).  
While this model appears to best describe the events after an acute infection, it is 
possible that other models are more relevant in other situations, such as chronic 
infection or non-infectious immunizations (66, 73).  After a non-virulent 
immunization with DCs pulsed with an L. monocytogenes (LM)-derived peptide, 
the presence of memory-phenotype antigen-specific CD8 T cells have been 
observed at the peak of the CD8 T cell response (68).  Furthermore, these 
memory-phenotype antigen-specific CD8 T cells provide comparable protective 
immunity to antigen-specific memory CD8 T cells generated after acute LM 
infection (68).  It has also been shown that CD8 T cells treated in vitro with IL-15 
or low doses of IL-2 acquire a memory phenotype, suggesting that these cells do 
not need to bypass the effector stage to become memory (67).  Thus, while 
memory CD8 T cells may be generated through mutliple different pathways, this 
work will focus on the linear model in which memory CD8 T cells differentiate 
from effector CD8 T cells.  
 
Lymphocytic choriomeningitis virus model of infection. 
 Lymphocytic choriomeningitis virus, or LCMV, is an arenavirus whose 
natural reservoir is Mus musculus (74).  Although a natural mouse pathogen, 
LCMV is known to cause disease in humans, mostly from exposure to infected 
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rodents (75).  LCMV is a non-cytopathic virus that causes a systemic infection, 
and almost all of the tissue damage associated with the infection is due to 
immunopathology (76).  Although many genetic variants of this virus exist, the 
strains that are used for this study are LCMV Armstrong (Arm) and LCMV clone 
13.  
 Infection of  H-2(b) restricted C57BL/6 mice with LCMV induces a strong 
Tc1 response, and immunity to LCMV is mediated almost entirely by CD8 T cells 
(77-80).  Accordingly, LCMV Arm infection elicits an enormous CD8 T cell 
response which peaks around day 8 post infection (55, 56).  Of the CD8 T cells, 
85-95% are CD44hi, and almost all of the CD44hi CD8 T cells are LCMV-specific 
(81).  Two immunodominant epitopes, DbNP396 and DbGP33, as well as other 
epitopes including KbGP34, DbGP276 and KbNP205, comprise approximately 
80% of the LCMV-specific response, and are derived from the glycoprotein (GP) 
and nucleoprotein (NP) of the virus, which are products of the S-RNA segment of 
LCMV (81-83).  Recently, epitopes derived from the L-RNA segment of the 
LCMV genome were identified, and these L epitopes roughly account for the 
remaining 20% of the LCMV-specific CD8 T cell response (82).  Infection with 
LCMV Arm lasts for 8-10 days, after which the virus is completely cleared. 
 LCMV clone 13 is a genetic variant of LCMV Arm which was isolated from 
the spleens of carrier mice that were neonatally infected with LCMV Arm (84).  
While both LCMV Arm and clone 13 infect fibroblasts and macrophages, neither 
infects lymphocytes well (85).  Two amino acid changes in LCMV clone 13 
account for its persistence after infection.  One mutation in the glycoprotein (F-
9
>L, position 260) provides LCMV clone 13 with greater affinity to its receptor, α-
dystroglycan, which allows the virus to infect a greater number of macrophages 
as well as infect DCs, something LCMV Arm is unable to do (85-88).  Another 
amino acid change in the viral polymerase (K->Q, position 1079) increases the 
viral replication rate, leading to greater virus yield after infection (85).  These two 
mutations lead to different patterns of dissemination, as LCMV Arm remains in 
the red pulp of the spleen, while LCMV clone 13 also invades the white pulp (87). 
 Infection of C57BL/6 mice with LCMV clone 13 leads to a chronic infection 
in which multiple tissues become infected.  LCMV clone 13 virus can be found in 
the spleen and liver for approximately one month after infection, in the serum for 
two to three months and in the kidney and brain for the life of the animal (89).  
LCMV clone 13 infection can also invade the bone marrow, lymph nodes and 
thymus, which leads to central tolerance early during chronic LCMV infection and 
in neonatally infected carrier mice (89).  LCMV clone 13 also elicits a strong CD8 
T cell response with kinetics that are similar to that of LCMV Arm (89).  Both 
LCMV Arm and clone 13 present the same CD8 T cell epitopes, which allows a 
direct comparison of CD8 T cell responses during infection (85, 86).  However, 
the overall CD8 T cell response during LCMV clone 13 is diminished compared 
to LCMV Arm due to the deletion of certain epitope-specific populations, resulting 
in mild lymphopenia (89-92).  Regardless, the availability and similarity of these 
two strains make LCMV a powerful tool in the study of CD8 T cell respones to 
chronic viral infections. 
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Antigen-specfic memory CD8 T cell differentiation after acute infection or 
vaccination. 
I. Generation of memory CD8 T cells. 
After an acute infection or vaccination, antigen-specific CD8 T cells 
become activated and differentiate into a heterogeneous pool of effector CTLs, 
as described above.  During the contraction phase, 90-95% of the effector 
population dies, and the remaining 5-10% survive to differentiate into memory 
CD8 T cells (66).  Apoptosis of CD8 T cells during this phase is mediated by the 
molecules such as Fas and Bim (93, 94).  After LCMV Arm infection, although 
memory precursors express high levels of CD127, expression of this marker is 
independent of IL-7 and does not confer any selective advantages (63, 95).  
Furthermore, memory precursors that are present within the effector population 
(d8 p.i.) are not yet able to respond to IL-7 and IL-15 signals in vivo (64).  It is 
important to note that memory differentiation of CTLs after acute infection occurs 
only after the infection has been completely cleared. 
As they differentiate, memory CD8 T cells acquire properties that allow 
them to confer long-term protection. Memory CD8 T cells have a resting 
phenotype and downregulate the expression of effector molecules, but upon 
restimulaton, can rapidly reacquire their effector function, including production of 
antiviral cytokines and cytolysis (43, 96-99).  In natural settings, the immune 
system is called upon to respond to a number of different infections.  It was 
originally thought that the size of the total memory CD8 T cell pool was 
constrained, and that with each new, heterologous infection, previously existing 
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memory populations would undergo attrition to make ‘room’ for new specificities 
(100, 101).  However, recent work by Vezys et al suggests that rather than 
undergo attrition, the memory CD8 T cell pool appears to increase in size to 
accommodate new specificities, and that previously existing populations remain 
intact (102).  It is not clear why this discrepancy has been observed, but could 
have important implications for vaccination strategies. 
Various components are required to generate functional memory CD8 T 
cells.  One key factor that is required for the proper differentiation of memory 
CD8 T cells is CD4 T cell help.  CD8 T cell responses to primary challenges are 
independent of CD4 T cell help, provided that sufficient inflammation is available 
to induce the maturation of DCs (43).  However, in the absence of CD4 T cells, 
memory CD8 T cells are deficient in secondary responses and do not appear to 
mature over time (103-105).  While the necessity of CD4 T cells in establishing a 
functional memory CD8 T cell population has been well described, the exact 
mechanism by which CD4 T cells provide help is still unclear.  Suggested 
mechanisms include CD40/CD40L interactions, via DCs or directly between CD4 
and CD8 T cells (39-41, 106), and the regulation of TRAIL expression on CD8 T 
cells (107).  IL-2 is required during the priming of CD8 T cells, so it is also 
possible that CD4 T cells may provide some help through early IL-2 production 
(108).  However, depending on the model of used to generate memory CD8 T 
cells, CD40/CD40L interactions and absence of TRAIL have been shown to be 
dispensible (109-112).  Furthermore, it is unclear as to when CD4 T cells provide 
help.  While originally thought to be necessary for the early ‘programming’ of 
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memory CD8 T cells (104, 113), it seems that CD4 T cells may be required for 
the mainenance, rather than the ‘programming’ of memory CD8 T cells (105).  
Also, while it is not clear what CD4 help imparts to a differentiating CTL, studies 
have shown that CD4 help may help ‘imprint’ a memory program through 
chromatin remodeling (114, 115).  Aside from CD4 help, certain inflammatory 
signals have been shown to be important for the generation of memory CD8 T 
cells.  Along with IL-2, depending on the priming agent, both IL-12 and type I 
interferons can support the differentiation of memory CD8 T cells (116, 117). 
 
II. Maintenance of memory CD8 T cells. 
 A major function of memory CD8 T cells is to provide protection against 
reinfection long after the primary challenge has been been encountered.  In order 
to do so, a memory CD8 T cell population must be stably maintained long-term.  
Original observations suggested that persistent antigen or interaction with MHC 
was necessary in order to maintain protective immunity (17, 118), but 
experiments in MHC class I knockout animals and adoptive transfer models have 
shown that antigen or interaction with MHC is not required (119, 120).  Upon the 
observation that adjuvants alone could drive transient, bystander proliferation of 
memory CD8 T cells (121), it was discovered that type I interferons induced the 
production of IL-15, which in turn acted directly on memory CD8 T cells (122).  
Memory CD8 T cells rely on the homeostatic cytokines IL-7 and IL-15 for their 
survival and self-renewal (73, 123, 124). IL-7 appears to provide a survival 
signal, most likely through the upregulation of pro-survival molecules such as 
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Bcl-2 (125, 126).  IL-15 mediates the slow, steady homeostatic proliferation of 
memory CD8 T cells (127, 128) which preferentially occurs in the bone marrow 
(129). 
 Since the self-renewal program that memory CD8 T cells undergo is 
reminiscent of stem cells, there has been interest in determining whether 
memory CD8 T cells possess any other stem-cell like qualities.  Unique 
populations of memory CD8 “stem cell” populations have been identified (130, 
131) in different inflammatory settings.  Comparisons of transcriptional profiles 
show that memory CD8 T cells are enriched for molecules that are also 
expressed by HSCs (132).  Expression of Bmi-1, a transcriptional repressor 
expressed by HSCs to prevent senescence, is upregulated in KLRG-1lo but not 
KLRG-1hi activated CTLs (133).  While intriguing, further studies are necessary to 
determine whether the ‘memory stem cell’ actually exists in memory populations 
generated after infection. 
 
III. Heterogeneity in the memory CD8 T cell population. 
Memory CD8 T cells continue to differentiate over an extended period of 
time, as a pool of less mature effector memory CD8 T cells (CD62Llo, CCR7lo; 
TEM) gradually converts to a population of central memory CD8 T cells (CD62Lhi, 
CCR7hi; TCM) (134, 135), although not all TEM may differentiate to TCM.  Some 
evidence suggest that a more terminally differentiated population of TEM may 
arise, perhaps from short-lived effector CD8 T cells (60, 65, 66), and that these 
TEM may never convert to TCM (136).  The lifespan of these ‘terminally 
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differentiated’ TEM, the role they may play in providing protective immunity and 
whether they are generated after different types of acute infections is not yet 
clear. 
As the conversion from TEM to TCM occurs, memory CD8 T cells also 
become CXCR3hi, CD43lo and CD27hi, indicating a more mature and less 
activated state (137).  Due to their differences in the expression of lymphoid 
homing markers, TEM and TCM also occupy different anatomical niches, with TEM 
localizing primarily in non-lymphoid tissues and TCM localizing in lymphoid organs 
(134, 138).  Functionally, TCM produce higher levels of IL-2 than TEM, have a 
higher proliferative capacity, may produce more antiviral cytokines such as TNFα 
and undergo more efficient homeostatic turnover (135, 139).  Upon secondary 
challenge, the protective capacity of TEM vs. TCM appears to depend on the route 
of infection and dissemination of the pathogen (i.e. systemic vs. local) (140, 141).  
Interestingly, it has also been shown that regardless of the subset, memory CD8 
T cells that have been ‘rested’ for a longer period of time after a primary 
challenge respond better than memory CD8 T cells that have been ‘rested’ for a 
short period of time (137, 142), indicating that maturation of the memory CD8 T 
cell population does not necessarily have to be accompanied by a phenotypic 
shift.    
While it is clear that the memory CD8 T cell population is dynamic, there is 
some controversy over the origins of the central and effector memory subsets.  
While considerable evidence suggests that the conversion from TEM to TCM is a 
linear path of differentiation (68, 135, 143, 144), some have suggested that the 
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two lineages may arise separately depending on the frequency of naïve 
precursors (136, 145, 146).  However, it has also been shown that many factors, 
including the strength of stimulation, clonal competition (143) and length of 
infection (68, 147) can affect the differentiation of TEM to TCM, and thus 
differences in precursor frequency may impact the rate of conversion (i.e. 
increasing precursor frequency leads to faster conversion). 
 
IV. Transcriptional control of memory differentiation. 
 The differentiation of CTLs from effector to memory CD8 T cells is 
accompanied by changes in gene expression (64).  Several transcription factors 
have been shown to play key roles in regulating this process.  The T-box factors 
Tbet and Eomesodermin (Eomes) have been shown to play critical roles in 
regulating CD122 expression and thus, IL-15 responsiveness in memory CD8 T 
cells (148).  Deletion of Tbet also corrects the defective TCM differentiation 
observed in memory CTLs that have not received CD4 help (149).  Blimp-1, a 
zinc-finger containing repressor, has been shown to play an important role in the 
activation and differentiation of CTLs.  Inactivation of Blimp-1 resulted in the 
improper activation of naïve T cells, which led to the accumulation of effector and 
memory-like populations (150, 151).  Both Tbet and Blimp-1 have been 
implicated in the fate decision between terminally differentiated effector and 
memory precursor after acute infection (Rutishauser et al, Immunity, in press; 
Kallies et al, Immunity, in press).  Other transcription factors such as Bcl6 and its 
homologue Bcl6b (152, 153), Id2 (154) and Bmi-1 (133) have also been shown to 
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play a role in the differentiation of memory CD8 T cells.  As more transcription 
factors are identified, it will be important to establish a molecular identity for 
memory CD8 T cells in order to better understand what happens when 
differentiation occurs improperly, as during chronic infections. 
 
CD8 T cell exhaustion during chronic infections. 
I. Properties of functionally exhausted CD8 T cells. 
 Proper memory differentiation occurs after acute infection or vaccination in 
the complete absence of antigen.  During chronic infection, however, the antigen 
persists, and this appears to have a profound impact on the differentiation of 
antigen-specific CD8 T cells.  First observed in the LCMV system, it was noted 
that ‘functionally exhausted’ antigen-specific CD8 T cells during chronic infection 
persisted but lost the ability to produce effector cytokines, and that the phenotype 
was more profound in the absence of CD4 help (90).  Subsequently, it was found 
that chronic infection could impact multiple properties of antigen-specific CTLs 
(89, 155), and that the loss of effector function occurred in a progressive manner 
(89, 155, 156).  IL-2 production, cytotoxicity and a high proliferative capacity are 
lost early during functional exhaustion, followed by TNFα production and finally, 
IFNγ production (89, 155, 156).  In extreme cases where antigen burden is 
particularly high, some antigen-specific CD8 T cells are physically deleted from 
the response (156, 157).  Functional exhaustion of CD8 T cells is not limited to 
chronic LCMV, as it has been described in other murine models of chronic 
infection such as polyoma virus, Friend’s leukemia virus, adenovirus and mouse 
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hepatitis virus (14).  Observations also extend to human chronic infections, 
including HIV, HCV and HBV and human T lymphotrophic virus (14).  It should be 
noted, however, that not all persistent infections lead to functional exhaustion.  
Persistent but latent infections such as CMV, EBV in humans and murine γHV 
leads to CD8 T cells that are dysfunctional but have intact effector functions (14). 
  One key characteristic of functionally exhausted antigen-specific CD8 T 
cells is their high expression of multiple inhibitory receptors (158-161).  A strong 
correlation has been shown between the amount and number of inhibitory 
receptors co-expressed per cell and the severity of dysfunction (160).  One 
inhibitory pathway that has received considerable attention is the PD-1/PD-L 
pathway.  First described within the LCMV system, PD-1 is highly expressed on 
antigen-specific CD8 T cells during chronic viral infection (162), and expression 
can be divided into two subsets of PD-1int and PD-1hi cells (163).  In vivo antibody 
blockade of this pathway led to selective re-invigoration of the PD-1int subset of 
CD8 T cells (163), resulting in vigorous proliferation and enhanced viral control 
(160, 162, 163).  It should be noted that all activated CD8 T cells upregulate PD-
1, but expression levels never reach that of exhausted CD8 T cells (162, 163).  
Since the initial observation, PD-1 expression on antigen-specific CD8 T cells 
has been noted during HIV (164, 165), HCV (166), and HBV (167), as well as 
during SIV (168).  PD-1 expression correlated directly with viral load and 
inversely with CD4 counts in HIV patients, and PD-1 levels declined in patients 
treated with HAART (164).  During HCV infection, CD8 T cells in the blood 
expressed less PD-1 than those found in the liver, suggesting that tissue-specific 
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expression of the inhibitory receptor may be dependent on viral load (169, 170).  
In vivo blockade in an SIV model led to increased proliferation and improved 
effector function of virus-specific CD8 T cells (162, 171).  In vitro blockades show 
that PD-1 directly mediates the survival of exhausted CD8 T cells, and that 
increased proliferation and improved effector function are likely secondary effects 
(163, 172).  Although the role inhibitory receptors play in the initiation of 
functional exhaustion is uncertain, it is clear that they regulate multiple, distinct 
aspects of T cell dysfunction.  Other inhibitory receptors expressed by exhausted 
CD8 T cells include LAG-3, CD160, 2B4, Tim-3 and CTLA-4 (158, 160, 161, 
173).  Along with PD-1, inhibitory receptors such as LAG-3 and CD160 regulate 
proliferation and cytotoxicity, respectively (160).  In order to further understand 
the biology of functionally exhausted CD8 T cells and the factors that influence 
their differentiation, this thesis will examine, in three chapters, the cell-intrinsic 
and extrinsic mechanisms regulating T cell dysfunction during chronic viral 
infection. 
 
II. Transcriptional control of functional exhaustion. 
 While significant work has been done with the role of inhibitory receptors 
during chronic infection, very little is known about the transcriptional control of 
functional exhaustion.  Gene expression studies show that functionally exhausted 
CD8 T cells differentially express over three hundred genes as compared to 
effector and memory CD8 T cells (158), suggesting that functional exhaustion is 
a unique differentiation state.  Many of these genes included transcription factors, 
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including Blimp-1, Tbet, and Eomes (158).  It is interesting to note these 
transcription factors play an important role in regulating the fate decision between 
terminally differentiated effector CD8 T cells and memory precursors after an 
acute infection (Rutishauser et al, Immunity, in press; Kallies et al, Immunity, in 
press)(60).  Chapter 2 of this thesis will explore the role of Blimp-1 in regulating 
functional exhaustion during chronic viral infection.  Our data show that Blimp-1 
plays a role in regulating key aspects of functional exhaustion, including the 
upregulation of inhibitory receptors.  With this work, we have identified a 
molecular mechanism underlying functional exhaustion, and have provided a 
novel potential target for future therapeutic strategies. 
 
III. Memory defects in functionally exhausted CD8 T cells. 
 Despite their loss of effector function, exhausted antigen-specific CD8 T 
cells persist indefinitely in chronically infected hosts (90, 174).  Although the 
exhausted CD8 T cell population survives long-term like memory CD8 T cells, 
there are clear alterations in the memory differentiation program during chronic 
viral infection.  Unlike memory CD8 T cells which gradually convert from TEM to 
TCM over time, exhausted CD8 T cells do not adopt the CD62Lhi CCR7hi 
phenotype associated with TCM (174-176).  While effector functions that are lost 
during functional exhaustion can, to some extent, be recovered after viremia is 
controlled (155), the memory defects described here remain even after viral 
burden begins to decrease (174, 177). 
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After acute infection, memory CD8 T cells are maintained by the 
homeostatic cytokines IL-7 and IL-15, a mechanism which is facilitated by the 
high expression of CD127 and CD122 (43).  However, during many chronic 
infections, including LCMV, γHV, HIV, HCV, HBV and others, virus-specific CD8 
T cells fail to upregulate these receptors (14).  Exhausted CD8 T cells also do not 
respond to IL-7 and IL-15 in vitro, and do not use these cytokines efficiently in 
vivo (174, 178-180).  The persistence of the exhausted CTLs in vivo and their 
inability to make use of the IL-7/IL-15 pathways raises the question as to how 
these cells are maintained long-term during chronic infection.  Two studies have 
explored the possibility that recent thymic emigrants (RTEs) may join the existing 
pool of virus-specific exhausted CD8 T cells.  One study infected thymectomized 
mice with LCMV clone 13 and found that the antigen-specific CD8 T cell 
population could be stably maintained over a long period of time without input 
from the thymus (181).  Another study, however, showed that congenically 
marked CD8 T cells specific for polyoma virus could not be maintained after 
adoptive transfer to a new, infection-matched host (182).  Furthermore, it was 
shown that RTEs could be primed by persistent antigen, and that these RTEs 
contributed to the dynamic phenotype of the antigen-specific CD8 T cell 
population (182).  Aside from RTEs, other possible maintenance signals include 
persistent antigen, an unidentified cytokine or growth factor or some unknown 
cell-cell contact.  In the third chapter, we investigated these possibilities and 
found that persistent antigen is the required signal for the maintenance of the 
exhausted CD8 T cell population, and that these cells are maintained by a unique 
21
proliferative mechanism.  We believe that our findings have important 
implications for the treatment of chronic infections in patients, where viral 
clearance or enhanced viral control could have an impact on the maintenance of 
protective immunity.   
 
IV. Extrinsic regulation of the differentiation of functional exhaustion. 
 The cellular changes that occur in functionally exhausted CD8 T cells are 
numerous.  Recently, several cell-extrinsic pathways have been identified that 
have an important impact on both the pathogenesis of infection as well as the 
differentiation of antigen-specific CD8 T cells.  During chronic LCMV infection, 
the immunosuppressive cytokine IL-10 was shown to play a role in suppressing T 
cell function (183, 184).  Genetic ablation of IL-10 production or treatment with 
αIL-10R antibody at the onset of infection prevented the infection from persisting 
and improved T cell responses (183, 184).  Furthermore, αIL-10R treatment after 
the establishment of infection enhanced viral control and led to an increase in 
IFNγ production from antigen-specific CD8 T cells (183, 184).  Since then, 
elevated IL-10 levels have been observed to correlate with viral load in HIV 
infected patients and in vitro blockade of the IL-10 pathway led to increased 
proliferation of HIV-specific CD8 T cells (185).  More recently, the cytokine IL-21 
was shown to play a critical role in regulating the functionality and survival of 
CD8 T cells (186-188).  The absence of IL-21 signaling in either IL-21-/- or IL-
21R-/- mice infected with LCMV clone 13 or high dose of LCMV Docile led to 
severe exhaustion and a gradual loss of the antigen-specific CD8 T cell 
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population, and that in turn led to impaired viral control (186-188).  It is unclear, 
however, whether IL-21 production (primarily from CD4 T cells) is higher or lower 
during chronic viral infection, as the two studies using LCMV clone 13 showed 
higher mRNA but lower protein as compared to LCMV Arm (186, 188).  Along 
with these two cytokines, the ‘inflammatory’ environment of LCMV clone 13 is 
markedly different than LCMV Arm infection (S. Blackburn, unpublished data), 
and it is likely that there are other factors present (or absent) during LCMV clone 
13 that could regulate T cell dysfunction.  Chapter 4 investigates the role of 
persistent ‘inflammation’ in the differentiation of exhausted CD8 T cells.  We find 
that ‘inflammation’ alone has a profound impact on memory differentiation, does 
not alter other key aspects of functional exhaustion such as the expression of 
inhibitory receptors.  Our results could have important implications in the design 
of vaccination strategies, particularly of people who are chronically infected, and 
have the potential to further our understanding of how functional exhaustion is 
regulated during chronic viral infection. 
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Chapter 2 
A role for the transcriptional repressor Blimp-1 in CD8 T cell 
exhaustion during chronic viral infection 
 
Abstract 
 After an acute infection, virus-specific CD8 T cells undergo memory 
differentiation once antigen has been cleared, resulting in a pool of highly 
functional memory CD8 T cells.  During chronic infection, however, virus-specific 
CD8 T cells follow an altered program of differentiation, resulting in a population 
of functionally exhausted CD8 T cells.  While multiple inhibitory pathways have 
been shown to play an important role in regulating different aspects of functional 
exhaustion, the transcriptional mechanism that leads to exhaustion has not been 
elucidated.  In this study, we describe a major role for Blimp-1 in CD8 T cell 
exhaustion during chronic viral infection.  We find that Blimp-1 represses the 
acquistion of important memory properties and promotes functional exhaustion 
by regulating the expression of inhibitory receptors.  Furthermore, our studies 
indicate that while high expression of Blimp-1 promotes functional exhaustion, 
moderate levels of Blimp-1 are required for effector function such as cytotoxcity.  
Thus, we define Blimp-1 as a transcriptional rheostat that balances expression of 
inhibitory receptors, memory differentiation and effector function. 
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Introduction 
 Functionally exhausted CD8 T cells have been identified and described in 
many different models of chronic viral infection.  The hallmarks of functional 
exhaustion include the hierarchical loss of effector function (14) and the high 
expression of multiple inhibitory receptors (158-160, 164, 173).  However, the 
molecular mechanisms that underlie these properties have not been investigated.  
Gene expression studies show there are a significant number of genes that are 
differentially expressed by exhausted CD8 T cells, including those encoding 
transcription factors such as Blimp-1 (158).  This suggests that there may be a 
unique transcriptional program guiding the differentiation of these cells.  In this 
chapter, we examine the role of transcription factor Blimp-1 in the regulation of 
functional exhaustion during chronic viral infection. 
 Blimp-1 is a zinc-finger containing transcriptional repressor that is perhaps 
best known for regulating fate decisions during the differentiation of activated B 
cells (189-191).  High expression of Blimp-1 leads to the repression of the 
memory B cell program and promotes the terminal differentiation of plasma cells 
(190).  Blimp-1 also plays a role in regulating the fate decisions of non-
hematopoeitic cells as well, including germ cells (192, 193) and hair follicle stem 
cells (194).  More recently, Blimp-1 was shown to be expressed in T cells, in 
which it regulates homeostasis and activation (150, 151).  Inactivating Blimp-1 
through mutation or deletion in naïve T cells led to an activated phenotype and 
the accumulation of effector and memory T cells (150, 151).  Blimp-1 also 
regulates the expression of effector molecules such as IFNγ (195), IL-2 (196) and 
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granzyme B (197) in T cells, and is induced by TCR signals as well as cytokines 
such as IL-2 and IL-4 (197, 198).  
Based on the role that Blimp-1 plays in regulating the fate decisions and 
differentiation in numerous cell types, we examined whether Blimp-1 could be 
playing a similar role in regulating the differentiation of exhausted CD8 T cells.  
We find that Blimp-1 is highly upregulated in antigen-specific CD8 T cells during 
chronic viral infection, and that expression correlated with severity of dysfunction 
and expression of inhibitory receptors.  The high inhibitory receptor levels and 
memory repression associated with CD8 T cell exhaustion were both reversed 
upon conditional deletion of Blimp-1.  However, haploinsufficient mice controlled 
virus more rapidly than either wt or the full conditional knockouts and indicated 
that some Blimp-1 expression is necessary to maintain some level of effector 
function.  Thus, our study suggests that Blimp-1 plays an important role in the 
regulation of exhaustion during chronic viral infection, and suggests that Blimp-1 
acts as a transcriptional rheostat, promoting CD8 T cell effector function when 
moderately expressed and CD8 T cell exhaustion when highly expressed.  
 
 
Materials and Methods  
Animals and viruses.  Four to six week old C57BL/6 mice were purchased from 
NCI.  B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J (Rosa26-YFP) mice were purchased 
from Jackson Laboratories.  BAC transgenic Blimp-1 YFP reporters were 
obtained from Eric Meffre (Yale University, New Haven, CT).  Prdm1flox/flox (f/f) 
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mice were obtained from Kathryn Calame (Columbia University, New York, NY), 
granzyme B-Cre mice were obtained from Joshy Jacob (Emory University, 
Atlanta, GA) and CD4-Cre mice were obtained from Steven Reiner (University of 
Pennsylvania, Philadelphia, PA).  Prdm1f/f mice were crossed with either 
granzyme B-Cre or CD4-Cre mice to generate prdm1f/f x Cre+, prdm1f/f x Cre-, 
prdm1f/+ x Cre+, prdm1f/+ x Cre- and prdm1+/+ x Cre+ mice.  Rosa26-YFP mice 
were crossed with granzyme B-Cre mice to generate Rosa26-YFP+ x Cre+ and 
Rosa26-YFP- x Cre+ mice.  Mice were infected with 2x105 plaque forming units 
(PFU) of LCMV Armstrong (Arm) i.p. or 2x106 PFU LCMV clone-13 (Cl-13) i.v. as 
described (89).  Virus was grown and viral titers were determined by plaque 
assay as described (89).  All animals were used in accordance with IACUC 
procedures. 
 
Lymphocyte isolation and flow cytometry.  Lymphocyte isolation from 
lymphoid and non-lymphoid tissues, surface stains, intracellular cytokine stains 
and CD107 assay were performed as previously described (89, 199).  All 
antibodies were purchased from Biolegend except for CD127, CD160, TNFa, IL-
2 (eBioscience), 2B4 (eBioscience, BD Biosciences) LAG-3 (AbD Serotec), 
granzyme B (Caltag) and MIP-1α (R&D Systems).  LIVE/DEAD dead cell stain, 
CFSE, CD62L, streptavidin-APC and streptavidin-Quantum dot 655 were 
purchased from Invitrogen.  MHC class I peptide tetramers were made and used 
as described previously (89).  All flow cytometry data was acquired on an LSRII 
(BD Biosciences) and analyzed by FlowJo (Treestar).  Pie charts were created 
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using the Pestle and SPICE programs, written by Mario Roederer (Vaccine 
Research Center, NIAID, NIH). 
 
Quantitative PCR.  Cells were sorted by flow cytometry on a FACSAria (BD 
Biosciences).  RNA extraction was performed using the Trizol protocol 
(Invitrogen).  cDNA was generated using the High Capacity cDNA Archive Kit 
(Applied Biosystems).  Relative quantification real-time PCR was performed on 
an ABI Prism 7000 using inventoried primers purchased from Applied 
Biosystems.  All samples were normalized to an endogenous control of HPRT, 
and gene expression was measured as a fold-change over expression in naïve 
CD44lo CD8 T cells. 
 
In vitro killing assays.  CD8 T cells were purified with magnetic beads (Miltenyi 
Biotec) from splenocytes of CKO, het and wt mice.  Briefly, splenocytes were 
labeled with magnetic beads specific for CD8α and then run through a MACS LS 
separation column according to the manufacturer’s protocol.  Target cells were 
either labeled with GP33 peptide or SIINFEKL peptide and CFSE labeled at two 
different concentrations.  Equal numbers of DbGP33+ CD8 T cells were plated at 
a 2:1 ratio with the labeled target cells and total cell numbers were normalized 
with naïve splenocytes.  The cells were incubated at 37C for 16-20 hrs and 
specific lysis was calculated as described (200). 
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Results 
Blimp-1 is highly expressed in functionally exhausted CD8 T cells during chronic 
viral infection. 
In order to investigate the role of Blimp-1 in CD8 T cell exhaustion during 
chronic viral infection, we began by examining the kinetics of Blimp-1 expression 
in antigen-specific CD8 T cells by quantitative PCR (qPCR).  DbGP33-specific 
CD8 T cells were sorted from the spleens of LCMV Arm or LCMV clone 13 
infected mice at d8, 15 and 30 post-infection (p.i.).  We found that at an early 
effector time point (d8 p.i.), there was little difference in Blimp-1 expression in 
DbGP33-specific CD8 T cells from either an acute or chronic viral infection (Fig 
1a).  During an acute infection, as the antigen-specific effector CD8 T cell 
population differentiated into a memory population, the levels of Blimp-1 slowly 
decreased.  However, during chronic viral infection, Blimp-1 expression was 
greatly upregulated between d8 and d15 p.i., and remained high out to d30 p.i. 
(Fig 1a).  Blimp-1 expression was also examined using a Blimp-1 YFP reporter 
mouse infected with either LCMV Arm or LCMV clone 13.  After infection, only 
activated, CD44hi CD8 T cells expressed YFP (data not shown).  At 8 days p.i., 
Blimp-1 YFP levels were similar in antigen-specific CD8 T cells during both Arm 
and clone 13 infections.  While Blimp-1 YFP expression slowly decreased after 
d8 p.i. during acute infection, YFP MFI increased after d8 p.i. during chronic 
infection (Fig 1b).  The difference in Blimp-1 YFP MFI between antigen-specific 
CD8 T cells from acute or chronic infection was not isolated to a single tissue, as 
we found Blimp-1 YFP expression to be higher in antigen-specific CD8 T cells in 
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Figure 1.  Blimp-1 is highly expressed in exhausted antigen-specific CD8 T 
cells during chronic viral infection.  A) Blimp-1 message by qPCR.  DbGP33+
T cells were sorted by FACS from LCMV Arm (acute) or clone 13 (chronic) 
infected mice at the indicated d.p.i.. Naive controls were CD44lo CD8 T sorted 
from Arm immune.  Error bars show range of expression in triplicate wells.  
B) Kinetics of Blimp-1 reporter expression after LCMV Arm or clone 13 infection.  
Histograms are gated on DbGP33+ CD8 T cells from the blood of LCMV Arm 
(shaded) or LCMV clone 13 (open) infection.  Data points in graph show Blimp-1 
YFP MFI of DbGP33+ CD8 T cells from LCMV Arm (black circles) or LCMV clone 
13 (white circles) at the indicated d.p.i..  Error bars are standard error of the 
mean (SEM).  N=2-3 mice per time point.  D) Blimp-1 YFP reporter MFI in tissues 
30 d.p.i. with LCMV Arm or clone 13.  Dot plot is gated on total CD8 T cells.  
Histograms are gated on DbGP33+ CD8 T cells from LCMV Arm (shaded) or 
LCMV clone 13 (open) infection.  Open red histograms show CD44lo CD8 T cells 
from LCMV Arm infection.
30
multiple lymphoid and non-lymphoid tissues during chronic infection as compared 
to acute infection (Fig 1c).  Thus, Blimp-1 was globally overexpressed in 
exhausted antigen-specific CD8 T cells during chronic viral infection.   
 
Blimp-1 correlates with severity of dysfunction and/or terminal differentiation 
during in exhausted CD8 T cells.  
The upregulation of Blimp-1 expression in virus-specific CD8 T cells 
during chronic viral infection corresponded with the onset of certain features that 
are the hallmarks of functional exhaustion, such as the high expression of 
inhibitory receptors.  To determine whether Blimp-1 expression correlated with 
inhibitory receptor expression, we first examined Blimp-1 expression in subsets 
of PD-1 expressing antigen-specific CD8 T cells during chronic viral infection.  
DbGP33-specific PD-1hi and PD-1int/lo cells were sorted and Blimp-1 mRNA was 
measured by qPCR.  We found that Blimp-1 expression was approximately 2-fold 
higher in the more terminally differentiated PD-1hi subset compared to the PD-
1int/lo subset (Fig 2a).  Furthermore, subsets of antigen-specific CD8 T cells that 
were high for other inhibitory receptors such as LAG-3, CD160 and 2B4 
expressed higher Blimp-1 YFP than subsets that were low (Fig 2b).  When we 
examined the number of different inhibitory receptors co-expressed on each cell, 
we found that those cells which expressed the highest number of inhibitory 
molecules had the highest Blimp-1 YFP MFI (Fig 2c).  We also observed a 
correlation between Blimp-1 YFP expression and the severity of functional 
exhaustion during chronic viral infection.  During LCMV clone 13, CD8 T cells 
31
DbGP33+
0 102 103 104 105
0
103
104
105
PD-1
D
b G
P3
3
hiintlo
0
20
40
60
0 102 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
Blimp-1 YFP
PD-1 LAG-3 2B4CD160
1482
904
1598
204
1629
497
1458
441
receptor hi
receptor lo
3 2 1 0
0
1000
2000
3000
# of inhibitory receptors
A.
B. C.
Figure 2.  Blimp-1 expression correlates with expression of inhibitory 
receptors on antigen-specific CD8 T cells during chronic viral infection.  
A) Blimp-1 mRNA in PD-1hi and PD-1int subsets of exhausted CD8 T cells. Plot is 
gated on wt CD8 T cells from spleen at d30 post LCMV clone 13 infection.  For 
qPCR, PD-1hi and PD-1int DbGP33+ CD8 T cells were sorted from the spleens of 
LCMV clone 13 infected wt mice.  Graph shows fold increase in Blimp-1 
expression over naive CD44lo CD8 T cells sorted from LCMV Arm immune mice.  
Error bars show range of expression in triplicate wells.  B) Blimp-1YFP reporter 
expression in inhibitory receptor hi vs. lo subsets of exhausted CD8 T cells at d30 
post LCMV clone 13 infection (spleen). Histograms are gated on inhibitory 
receptor lo (shaded) or hi (open) DbGP33+ CD8 T cells.  Numbers in gray are 
YFP MFI of shaded histograms, numbers in black are YFP MFI of open 
histograms.  C) Correlation of Blimp-1 expression and number of inhibitory 
receptors expressed.  Blimp-1 YFP reporter mice were infected with LCMV clone
13 and inhibitory receptor expression was determined on DbGP33+ CD8 T cells
from the spleen at d30 p.i..  Boolean gating established the populations that
expressed a combination of 3, 2, 1 or no inhibitory receptors and Blimp-1 YFP
MFI was determined for each subgroups.  Graph represents two independent
experiments.
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specific for immunodominant epitopes such as DbNP396 become severely 
exhausted and are often physically deleted from the CD8 T cell response.  We 
found that DbNP396-specific CD8 T cells had a higher Blimp-1 YFP MFI than 
DbGP33-specific CD8 T cells during LCMV clone 13, while Blimp-1 driven YFP 
expression was similar between these two populations after LCMV Arm infection 
(Fig 3).   Thus, Blimp-1 expression was higher in exhausted virus-specific CD8 T 
cells during chronic infections than in fully functional CD8 T cells after acute 
infection, and Blimp-1 expression correlated with increased severity of T cell 
dysfunction and/or terminal differentiation. 
 
Blimp-1 alters the differentiation of virus-specific CD8 T cells during chronic viral 
infection. 
Blimp-1 has been shown to play a role in T cell activation and 
homeostasis (150, 151), and based on the dramatic increase of Blimp-1 
expression we wanted to determine whether Blimp-1 played a role in regulating 
functional exhaustion during chronic viral infection.  To examine this, prdm1, the 
gene encoding Blimp-1, was conditionally deleted.  The prdm1flox/flox mice (191) 
were crossed to mice expressing Cre under the CD4 promoter, which deletes 
Blimp-1 in T cells at the double positive stage of T cell development.  The 
prdm1flox/flox x CD4-Cre mice will be referred to as CD4-Cre CKO mice.   CD4-Cre 
CKO mice and wt littermates were infected with LCMV Cl-13 and both viral 
control and T cell responses were examined ~30 days p.i..  Deletion of Blimp-1 in 
antigen-specific CD8 T cells restored a memory phenotype, as the cells were 
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Figure 4.  CD8 T cell responses in CD4-Cre driven Blimp-1 conditional 
knockout mice.  CD4-Cre CKO and wt littermates were infected with LCMV
clone 13 and CD8 T cells were analyzed in the spleen at d30 p.i..  A) Phenotype 
of wt and CD4-Cre CKO antigen-specific CD8 T cells.  Plots are gated on total 
CD8 T cells.  Numbers in plots show percent of DbGP33+ CD8 T cells that are 
high for each marker.  B) Granzyme B expression in wt and CD4-Cre CKO 
antigen-specific CD8 T cells.  Plots are gated on total CD8 T cells, histograms are 
gated on DbGP33+ CD8 T cells.  Numbers above gates show percent of 
DbGP33+ CD8 T cells that are granzyme Bhi.  C) Effector function of wt and 
CD4-Cre CKO antigen-specific CD8 T cells.  Splenocytes were stimulated with 
GP33 peptide for 5 hrs at 37C.  Plots are gated on total CD8 T cells.  Numbers in 
plots show percent of IFNγ+ CD8 T cells that also produce a second cytokine.
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CD127hi and CD62Lhi (Fig 4a).  Virus-specific CD8 T cells lacking Blimp-1 
expressed less granzyme B than wt virus-specific CD8 T cells, but produced 
higher levels IL-2 (Fig 4b,c).  However, despite acquiring a memory phenotype 
and having slightly improved effector function, the CD4-Cre CKO mice were 
unable to control the infection (Fig 5).  Viral titers were higher in multiple tissues 
in the CD4-Cre CKO mice as compared to wt mice (Fig 5). 
Since CD4-Cre conditionally deletes Blimp-1 prior to T cell activation and  
Blimp-1 has been shown to play a role during activation (150, 151), it is difficult to 
ascertain whether the differences observed between the CD4-Cre CKO and wt 
mice are due to an altered T cell compartment and improper activation, or due to 
the action of Blimp-1 on the differentiation of exhausted CD8 T cells.  Thus, to 
avoid any potential complications arising from the lack of Blimp-1 during T cell 
activation, prdm1flox/flox mice were crossed with mice expressing the Cre 
recombinase under the human GranzymeB promoter (gzmB-Cre) (201).  These 
conditional knockout mice will heretofore be referred to as CKO mice.   
To first determine the activity of the gzmB-Cre, we crossed the gzmB-Cre 
mice to Rosa26-stopfl/fl-YFP mice (Rosa26-YFP), which have a floxed stop codon 
upstream of the gene encoding YFP within the Rosa26 locus.  Upon Cre 
activation, the stop codon is excised and YFP is expressed.  Granzyme B is 
expressed in CD8 T cells 1-2 days after activation (72) and accordingly, we 
observed YFP expression in CD25+ CD8 T cells 3 days post-infection with LCMV 
clone 13 (Fig 6).  By d6 p.i., the majority of antigen-specific CD8 T cells were 
YFP+, indicating Cre recombination had occurred in most of the responding CD8 
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T cells.  It is still possible, however, that previously expressed Blimp-1 protein 
could temporarily persist after the deletion of prdm1. 
CKO and wildtype (wt) littermates were infected with LCMV clone 13, and 
T cell responses and viral control were examined 30 days p.i..  Unlike the CD4-
Cre CKO mice, the CKO mice had viral titers in the serum and tissues that were 
similar to wt through the first 20-30 days p.i. (Fig 7a).  The frequency of antigen-
specific CD8 T cells in the CKO mice was slightly elevated in the spleen and 
lymph node, and similar to wt in other tissues such as the bone marrow and liver 
(Fig 7b). In particular, the DbNP396-specific population, which is often deleted 
during chronic viral infection, was rescued to a greater degree in the CKO mice 
than populations specific for GP33 or another LCMV epitope, GP276 (Fig 7b).  
Contraction of the virus-specific CD8 T cell population in the CKO mice also 
appeared to be slightly delayed compared to wt (Fig 7b).  Like the CD4-Cre CKO 
mice, virus-specific CD8 T cells from the CKO mice also expressed CD127 and 
CD62L at a level similar to memory CD8 T cells from Arm immune mice (Fig 7c).  
Virus-specific CD8 T cells from the CKO cells also showed only a modest 
improvement in the production of the cytokines.  While IL-2 production was 
restored to levels near to that produced by memory CD8 T cells from Arm 
immune mice for both DbGP33- and DbNP396-specific CD8 T cells, TNFα 
production was still much lower than after an acute infection (Fig 7d, data not 
shown).  CKO virus-specific CD8 T cells also expressed lower levels of the 
chemokine MIP-1α than wt (Fig 7d).  Together, our data show that while Blimp-1 
alone may not regulate effector function in exhausted CD8 T cells, high levels of 
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Figure 7.  CD8 T cell responses in gzmB-Cre driven Blimp-1 conditional
knockout mice.  CKO mice and wt littermates were infected with LCMV clone 
13 and viral control and CD8 T cell responses were measured at 30 d.p.i. unless 
otherwise noted.  A) Viral control.  Viral load was measured by plaque assay at
the indicated days in the serum and d30 p.i. in all other tissues.  Error bars in 
serum are SEM, dashed line shows limit of detection.  N=3-10 mice per time 
point.  Data is representative of four independent experiments.  B) Absolute
number of antigen-specific CD8 T cells in wt and CKO mice.  Frequency of 
DbGP33+ CD8 T cells was measured in the blood at indicated time points.  
Absolute number of tetramer+ CD8 T cells was measured in each tissue at d30 
p.i..  Numbers above spleen graph show fold increase of CKO over wt for each
tetramer+ population.  Error bars are SEM, and n=4-8 for each tissue.  Data
represents three independent experiments.  (Figure continued on next page.)  
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Figure 7 (cont).  CD8 T cell responses in gzmB-Cre driven Blimp-1 conditional knockout mice.  C) Phenotype of wt 
and CKO CD8 T cells in the spleen.  Plots are gated on total CD8 T cells.  Numbers in leftmost plots show percent of total 
CD8 T cells that are DbGP33+.  Numbers in middle and righthand plots indicate percent of DbGP33+ CD8 T cells that are
positive for each marker.  Graphs represent two independent experiments, Arm indicates marker expression for memory
CD8 T cells from Arm immune mice (~d30 p.i.).  Error bars are SEM.  For CD127, *p=0.04, **p=0.002 by Student’s t-test.
D) Effector function of wt and CKO antigen-specific CD8 T cells compared to memory CD8 T cells (d30+ Arm immune).
Splenocytes were stimulated with GP33 peptide for 5 hrs. at 37C.  Plots are gated on CD8 T cells.  Numbers in each plot
show the percent of IFNγ+ CD8 T cells that also produce the second indicated cytokine.  Numbers are graphed to the
right.  
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Blimp-1 may repress memory CD8 T cell differentiation during chronic viral 
infection. 
 
Blimp-1 regulates the expression of inhibitory receptors on exhausted CD8 T 
cells. 
 Since high Blimp-1 levels are associated with the high expression of 
inhibitory receptors on exhausted CD8 T cells (Fig 2), we next examined the 
expression of inhibitory molecules in the CKO mice.  At d30 post LCMV clone 13 
infection, DbGP33-specific CD8 T cells from wt mice expressed high levels of 
PD-1 and LAG-3, and subsets of the DbGP33-specific CD8 T cell population also 
expressed high levels of CD160 and 2B4 (Fig 8a).  In the CKO mice, however, 
the DbGP33-specific CD8 T cells expressed nearly 2-fold lower levels of both 
PD-1 and LAG-3 (Fig 8a).  Furthermore, the subsets of CD160hi and 2B4hi 
DbGP33-specific CD8 T cells present in the wt population was absent in the CKO 
mice (Fig 8a).  We also assessed the number of different inhibitory molecules 
expressed by each cell in the CKO and wt mice by multi-parameter flow 
cytometry.  We found that within the DbGP33-specific CD8 T cell population, the 
majority of the cells expressed a combination of three or all four inhibitory 
receptors at once (Fig 8a).  However, within the CKO mice, very few cells 
expressed all four inhibitory receptors.  Rather, most of the population expressed 
either no inhibitory receptors or just one (Fig 8a).  This pattern of expression was 
not isolated to just the DbGP33-specific population.  Total activated CD44hi CD8 
T cells from the CKO mice also had lower levels of PD-1 and LAG-3 than the wt 
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Figure 8.  Blimp-1 regulates inhibitory receptor expression on antigen-
specific CD8 T cells during chronic viral infection.  CKO and wt littermates
were infected with LCMV clone 13 and CD8 T cells from the spleen were 
analyzed 30 d.p.i.. A) Inhibitory receptor expression on antigen-specific CD8 T 
cells from wt and CKO mice.  Plots are gated on total CD8 T cells.  Histograms
are gated on DbGP33+ CD8 T cells.  Numbers above the gates indicate the
percentage of DbGP33+ CD8 T cells in each gate.  Numbers in red are the MFI
of each marker.  Pie charts show DbGP33+ CD8 T cell populations from wt and
CKO mice.  Each colored slice indicates the fraction of DbGP33+ CD8 T cells
that express a combination of 4, 3, 2, 1 or no inhibitory receptors.  B) Inhibitory
receptor expression in total CD44hi CD8 T cells in wt (shaded) or CKO (open)
mice.  Open red histograms represent CD44lo CD8 T cells from wt mice.
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CD44hi CD8 T cells, and very few activated CD8 T cells from the CKO mice 
expressed any CD160 or 2B4 (Fig 8b).  Together, our data show that Blimp-1 
plays a key role in regulating the elevated levels and co-expression of inhibitory 
receptors on exhausted CD8 T cells during chronic viral infection. 
 
Blimp-1 haploinsufficiency leads to rapid viral control during chronic viral 
infection. 
 Lower expression of inhibitory receptors on the CKO CD8 T cells 
suggested that long-term viral control may be enhanced.  However, since Blimp-
1 has been shown to regulate effector functions such as granzyme B expression 
(197), we also infected mice that were conditionally haploinsufficient for Blimp-1 
(prdm1fl/+ x gzmB-Cre; conditional hets) in order to examine the impact of 
decreased Blimp-1 expression on long-term viral control without the complication 
of altered T cell function.  When infected with LCMV clone 13, wt mice controlled 
viremia about 2 months p.i., and CKO mice maintained high serum titers (Fig 9a).  
Conditional haploinsufficiency for Blimp-1, however, resulted in viremia control 
that was more rapid than either the CKO or wt mice (Fig 9a).  The conditional het 
mice also had lower viral titers in multiple tissues compared to wt or CKO mice 
(Fig 9a).  To determine whether haploinsufficiency of Blimp-1 would also impact 
inhibitory receptor expression, we examined PD-1 at day 15 p.i., a time point 
when viral titers between the three groups of mice were similar (Fig 9b).  Virus-
specific CD8 T cells from the conditional het mice expressed significantly lower 
levels of PD-1 compared to wt mice (Fig 9b).  Furthermore, conditional het mice 
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Figure 9.  Blimp-1 haploinsufficiency in antigen-specific CD8 T cells leads 
to rapid viral control.  A) Viral titers in CKO, het and wt littermates d60 post
LCMV clone 13 infection.  Viral load was determined in the serum on the 
indicated days and in the tissues by plaque assay.  Dashed lines represent limit 
of detection for each tissue.  Data is representative of three independent 
experiments, n=3-17.  For kidney titers, wt vs. het *p=0.03, wt vs. CKO 
**p=0.003, het vs. CKO **p=0.002 by Student’s t-test.  B) PD-1 expression on 
antigen-specific CD8 T cells from CKO, het and wt mice.  PD-1 MFI was
measured on DbGP33+ CD8 T cells from the blood at d15 p.i.  Data is 
representative of three independent experiments.  Wt vs. het **p=0.007, wt vs.
CKO *p=0.01 by Student’s t-test.  Plots are gated on total CD8 T cells from the 
blood.  Numbers in red indicate the PD-1 MFI of the DbGP33+ CD8 T cells.
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also appeared to express slightly less PD-1 than CKO mice (Fig 9b).  Thus, while 
complete Blimp-1 insufficiency (CKO) resulted in poor long-term viral control, 
limiting Blimp-1 expression to a single intact copy of prdm1 was sufficient to both 
enhance viral control and decrease PD-1 expression on virus-specific CD8 T 
cells. 
 
Blimp-1 conditional heterozygosity leads to better maintenance of cytotoxicity 
than conditional knockouts. 
 To determine the cellular basis behind the difference in the kinetics of 
virus control, we first examined the number of antigen-specific CD8 T cells in the 
wt, conditional het and CKO mice.  The frequency of DbGP33-specific CD8 T 
cells in all three groups remained similar up to the first month p.i. (Fig 10a).  
However, the frequency of DbGP33-specific CD8 T cells in the blood continued 
to decline in the CKO mice whereas the frequency stabilized in both the wt and 
conditional hets and led to significant differences between the three groups (Fig 
10a).  When we examined the absolute number of antigen-specific CD8 T cells in 
the spleen, however, we found that the general trend did not change between the 
first and second months p.i. (Fig 10b,c).  We did observe, however, a small 
decrease in the number of DbNP396-specific CD8 T cells in the CKO mice 
between months 1 and 2 p.i., while this population was maintained in the 
conditional het mice (Fig 10c).  We next examined the functional properties of 
virus-specific CD8 T cells from the CKO, conditional het and wt mice.  The ability 
of virus-specific CD8 T cells from CKO and conditional het mice to co-produce 
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Figure 10.  Absolute number of antigen-specific CD8 T cells in CKO, haploinsufficient and wt mice.  CKO, 
conditional het and wt littermates were infected with LCMV clone 13.  Absolute numbers of LCMV-specific CD8 T cells
were measured in the blood and spleen at d30 or d60 p.i..  A) Frequency of DbGP33+ CD8 T cells was measured in 
blood at the indicated time points.  Error bars are SEM, n=4-15 per time point.  Graph is representative of three
independent experiments.  At d30, wt vs CKO *p=0.04, het vs. CKO *p=0.008.  At d50, wt vs. het *p=0.02, het vs. CKO
*p=0.006.  At d60, het vs. CKO ***p=0.0008.  All statistics measured by Student’s t-test.  B) Absolute number of tetramer+ 
CD8 T cells in the spleen at 30 d.p.i..  Data is representative of two independent experiments.  N=3-4 mice per group.  
Error bars are SEM.  C) Absolute number of tetramer+ CD8 T cells in the spleen at d60 p.i.  Data is representative of two 
independent experiments.  N=3-4 mice per group.  Error bars are SEM.  For het vs. CKO, *p=0.02, for wt vs. CKO *p=0.02 
by Student’s t-test.
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effector cytokines TNFα or IFNγ was not significantly different from wt cells, 
although the amount of IFNγ produced per cell was reduced in the CKO mice (Fig 
11a,b).   One copy of prdm1, however, was sufficient to restore co-production of 
MIP-1α and IFNγ to wt levels, and was also sufficient to repress IL-2 production 
(Fig 11a).  Virus-specific CD8 T cells from CKO, conditional het and wt mice 
were all equally capable of degranulation as measured by CD107 (Fig 11b).  
Blimp-1 has been implicated in the expression of granzyme B (197), and when 
examined, we found that antigen-specific CD8 T cells from the CKO were 
deficient in the expression of this cytotoxic granule as compared to the 
conditional het or wt mice (Fig 11c).  The loss of granzyme B expression is most 
likely due to loss of Blimp-1 expression rather than any competition between the 
hGzmB-Cre and endogenous granzyme B promoters, as CD8 T cells from the 
CD4-Cre CKO mice also show loss of granzyme B (Fig 4b).  While the killing 
ability of exhausted CD8 T cells is not as potent as memory CD8 T cells, 
exhausted CD8 T cells do retain residual cytotoxicity (89).  To test whether 
decreased granzyme B would impact the ability of CKO antigen-specific CD8 T 
cells to kill infected target cells, an in vitro killing assay was performed.  CD8 T 
cells from the CKO mice were deficient in their ability to lyse peptide-coated 
target cells at both early and late time points during chronic LCMV infection (Fig 
11d).  Wt and conditional het CD8 T cells, while not as efficient as memory CD8 
T cells, acquired and maintained their ability to kill (Fig 11d,e).  Thus, conditional 
deficiency indicated a role for Blimp-1 in controlling some aspects of T cell 
exhaustion, but complete loss of Blimp-1 also compromised a key CD8 T cell 
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Figure 11.  Blimp-1 regulates cytotoxicity in antigen-specific CD8 T cells during chronic viral infection.  CKO, het
and wt littermates were infectd with LCMV clone 13 and analyzed at d30 p.i unless otherwise noted.  A) Function of CD8
T cells from CKO, het and wt mice.  Splenocytes were stimulated with GP33 peptide for 5 hrs at 37C, and percent of
IFNγ+ CD8 T cells that also produced the second indicated cytokine was determined by ICS.  Data are representative of
two independent experiments, n=4-6.  Error bars are SEM.  B) Splenocytes were stimulated with GP33 peptide and
degranulation based on CD107 staining was determined.  Plots are gated on total CD8 T cells.  Numbers in plots indicate
MFI of IFNγ.  Graph shows number of DbGP33+ CD8 T cells that are also CD107+.  Data represents two independent 
experiments.  Error bars are SEM. (Figure continued on next page.)
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Figure 11 (cont.)  Blimp-1 regulates cytotoxicity in antigen-specific CD8 T cells during chronic viral infection.
C) Granzyme B expression in CD8 T cells from CKO, het or wt mice.  Dot plots are gated on total CD8 T cells from
the spleen and histograms are gated on DbGP33+ CD8 T cells.  Numbers above the gates indicate the percent of 
DbGP33+ CD8 T cells that express granzyme B.  D) Specific killing by CD8 T cells from CKO, het and wt mice as
determined by an in vitro killing assay on d8 and d30 p.i. with LCMV clone 13.  Equal number of DbGP33+ CD8 T cells
from the spleen were plated with GP33 peptide labeled target cells at a 2:1 effector to target ratio.  After 16-20 hrs, 
specific lysis was calculated.  Error bars are SEM for triplicate wells.  E) Specific killing by memory CD8 T cells from Arm 
immune mice.B6 mice containing ~3x104 P14 T cels were infected with LCMV Arm.  After more than 30 days, P14 CD8 
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20 hrs, specific lysis was calculated.
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effector function that is partially maintained by exhausted CD8 T cells with either 
one or both copies of prdm1. 
 
Blimp-1 acts in a cell-intrinsic manner in exhausted CD8 T cells. 
  While the data described above suggest that Blimp-1 regulates key 
aspects of CD8 T cell exhaustion such as the expression of inhibitory receptors, 
they do not rule out the possibility that Blimp-1 may be acting in a manner that is 
not cell-intrinsic.  Use of the gzmB-Cre may lead to loss of Blimp-1 from other cell 
types, and differences in the infectious environment, such as pathogenesis and 
viral load, between the three groups of mice could impact CD8 T cell 
differentiation.  In order to address these issues, mixed bone marrow (BM) 
chimeras were generated by injecting equal numbers of B and T cell depleted 
bone marrow from Ly5.1+ wt and Ly5.2+ CKO mice into irradiated Ly5.1+ wt 
recipients (Fig 12a).  Once fully reconstituted, the BM chimeras were infected 
with LCMV clone 13 and the CD8 T cells were analyzed four weeks p.i..   
In the BM chimeras, virus-specific CD8 T cells lacking Blimp-1 displayed a 
phenotype that was distinct from the wt virus-specific CD8 T cells.  As in the 
separate mice, CKO CD8 T cells from the BM chimeras acquired a memory-like 
phenotype with high levels of CD127 and CD62L, while wt cells remained 
CD127lo and CD62Llo (Fig 12b).  Also, as in the separate mice, CKO virus-
specific CD8 T cells from the BM chimeras also co-produced more IFNγ and IL-2, 
slightly more TNFα, and less MIP-1α than wt virus-specific CD8 T cells (Fig 12c).  
Furthermore, granzyme B expression was also decreased in the CKO antigen-
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Figure 12.  The role of Blimp-1 in CD8 T cells during chronic viral infection
is cell-intrinsic.  A) Experimental design for the generation of mixed BM
chimeras reconstituted with prdmf/f x gzmB-Cre (part B-E) or prdm1f/f x CD4-Cre
(part F) BM.  B) Phenotype of CD8 T cells from mixed BM chimeras.  Leftmost
plot is gated on total CD8 T cells from the spleen.  Top row of plots is gated on
Ly5.2+ CD8 T cells (CKO) and bottom row is gated on Ly5.2- CD8 T cells (wt).
Numbers in plots indicate the percentage of DbGP33+ CD8 T cells positive for 
each marker.  Numbers are graphed to the right.  Data are representative of two
experiments, n=4.  Error bars are SEM.  For CD127, **p=0.005 and for CD62L,
*p=0.01 by Student’s t-test.  C) Effector function of CD8 T cells from mixed BM 
chimeras.  Splenocytes were stimulated with GP33 peptide for 5 hrs at 37C.  Top
row of plots indicate the percentage of IFNγ+ CD8 T cells that also produce a
second cytokine.  D) Granzyme B expression in CD8 T cells from mixed BM 
chimeras.  Plots are gated on CD8 T cells from the spleen.  Histograms are gated
on DbGP33+ CD8 T cells.  Top row is CKO and bottom is wt.  Numbers above
gates show percent of DbGP33+ CD8 T cells that express granzyme B.
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specific CD8 T cells as compared to wt (Fig 12d).  When inhibitory receptor 
expression was assessed in the BM chimeras, we found that virus-specific CD8 
T cells lacking Blimp-1 expressed less PD-1 and slightly less LAG-3 than the wt 
cells, while the subset of CD160hi and 2B4hi cells present in the wt virus-specific 
CD8 T cell population was absent in the CKO population (Fig 13a).  When the 
co-expression of inhibitory receptors was examined in the BM chimeras, we 
again found that a much larger fraction of the wt virus-specific CD8 T cell 
population expressed three or four inhibitory receptors at once as compared to 
the CKO virus-specific CD8 T cells (Fig 13a).  In parallel experiments, mixed BM 
chimeras using wt and CD4-Cre CKO bone marrow were also generated.  We 
observed similar patterns of memory differentiation, effector function and 
inhibitory receptor expression as we observed with the CKO BM chimeras (data 
not shown, Fig 13b), suggesting that the changes observed in the CKO CD8 T 
cells were not due to the timing of cre-mediated recombination or deletion of 
Blimp-1 in cytotoxic cell lineages other than CD8 T cells. Together, our data 
suggest that Blimp-1 has a cell-intrinsic role in regulating central features of T cell 
exhaustion such as inhibitory receptor expression, and identify Blimp-1 as a 
transcriptional regulator of CD8 T cell exhaustion during chronic viral infections. 
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Figure 13. Blimp-1 cell-intrinsically regulates the expression of inhibitory
receptors on exhausted CD8 T cells during chronic viral infection.  BM
chimeras generated with CKO and wt or CD4-Cre CKO and wt were infected with
LCMV clone 13.  A) Inhibitory receptor expression on CD8 T cells from mixed BM
chimeras.  Histograms are gated on wt DbGP33+ (shaded) or CKO DbGP33+
(open) CD8 T cells.  Pie charts show either wt or CKO DbGP33+ CD8 T cells.  
Colored slices indicate the fraction of the total population that expressed a 
combination of 4, 3, 2, 1 or no inhibitory markers.  B) Inhibitory receptor 
expression on CD8 T cells from mixed CD4-Cre BM chimeras.  Histograms are
gated on wt DbGP33+ (shaded) or CKO DbGP33+ (open) CD8 T cells.  Pie
charts show either wt or CKO DbGP33+ CD8 T cells.
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Discussion 
In this study, we identify an important role for the transcriptional repressor 
Blimp-1 in regulating several defining features of CD8 T cell exhaustion during 
chronic viral infection.  Exhausted CD8 T cells had substantially higher 
expression of Blimp-1 compared to functional effector or memory CD8 T cells 
generated following acute infection.  This higher expression of Blimp-1 correlated 
with high inhibitory receptor levels and repression of memory T cell properties.  
Conditional deletion of Blimp-1 led to the restoration of some key aspects of 
memory (i.e. CD127 and CD62L expression, IL-2 production) and decreased 
expression of inhibitory receptors.  Despite this, however, the full CKO mice did 
not resolve chronic infection, while haploinsuffcient mice controlled infection 
more rapidly than both wt and CKO mice.  This suggested that while 
overexpression of Blimp-1 can promote functional exhaustion and the repression 
of memory differentiation, some Blimp-1 is necessary in order to acquire and/or 
maintain important effector functions, such as cytotoxicity.  Thus, Blimp-1 
appears to be acting as a molecular rheostat, acting to regulate effector function 
at low levels, while both promoting functional exhaustion and repressing memory 
at high levels. 
CD8 T cell exhaustion is a common feature of many chronic viral 
infections in both animal models as well as in humans and is a likely reason for 
poor control of infection in these settings (14).  High and sustained expression of 
PD-1 has emerged as a hallmark of T cell exhaustion, and blocking the PD-1:PD-
L pathway can re-invigorate immune responses during persisting infections (160, 
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162, 171).  In this study we found that Blimp-1 expression was 2-3 times higher 
in the more terminally differentiated PD-1hi subset of exhausted CD8 T cells 
compared to the PD-1int/lo subset, which can be ‘revived’ by antibody blockade 
(163).  Other inhibitory receptors, including LAG-3, 2B4 and CD160, are also 
upregulated by exhausted CD8 T cells and these pathways cooperate to 
negatively regulate CD8 T cell responses during chronic viral infection (158, 
160).  Blimp-1 appeared to cell-intrinsically regulate expression of these 
additional inhibitory receptors since the absence of Blimp-1 resulted in reduced 
expression of PD-1, LAG-3, 2B4 and CD160 by virus-specific CD8 T cells at later 
time points during chronic infection.  However, PD-1 levels were higher on CKO 
virus-specific CD8 T cells at early time points (d8 p.i.) but had decreased below 
wt levels by d15 p.i. (data not shown).  This suggests at least two different 
mechanisms by which Blimp-1 regulates high inhibitory receptor expression: 1) 
direct (or indirect) transcriptional regulation, or 2) survival of highly exhausted 
CD8 T cell subsets.  The expression of inhibitory molecules occurs in a 
hierarchical manner, with PD-1 and LAG-3 most widely expressed, followed by 
2B4 (158, 160).  Only the most severely exhausted CD8 T cells appear to 
upregulate CD160 (158, 160).  The loss of CD160 and 2B4 expression as well as 
the decrease in the PD-1hi and LAG-3hi subpopulations could indicate that 
expression of these inhibitory receptors does not occur, or the most highly 
dysfunctional cells have undergone apoptosis.  Knockdown of Blimp-1 has been 
shown to decrease the survival of transformed plasma cells (202), thus it is 
possible that Blimp-1 may be acting in a similar manner in virus-specific CD8 T 
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cells early during chronic viral infection.  Further work is necessary to determine 
the exact mechanism by which Blimp-1 regulates this aspect of functional 
exhaustion. 
Despite lower expression of inhibitory receptors in the absence of Blimp-1, 
these CD8 T cells remained poor cytokine producers.  One possibility is that 
other negative regulatory pathways compensate in this setting.  Alternatively, 
Blimp-1 could positively regulate expression of antiviral cytokines, either directly 
or indirectly.  A third possibility is that Blimp-1 controls one “module” of the 
transcriptional program of T cell exhaustion which includes inhibitory receptor 
expression and memory repression, while another layer of transcriptional control 
also influences expression of antiviral cytokines. Such an idea of overlapping 
transcriptional modules is emerging for Foxp3+ Tregs (203, 204).  Future studies 
are necessary to dissect additional transcriptional pathways associated with T 
cell exhaustion and Blimp-1-independent regulation of cytokine production.  It will 
also be important to compare functional changes in exhausted CD8 T cells that 
occur following antibody-mediated inhibitory receptor blockade versus temporal 
deletion of Blimp-1.   
The amount of Blimp-1 expressed also appeared to have a crucial impact 
on CD8 T cell differentiation and exhaustion. Mice with one intact copy of the 
prdm1 gene were not intermediate between wt and CKO mice, but rather 
achieved more efficient control of infection than wt or CKO mice.  Many 
transcription factors function as transcriptional on/off switches (205).  In contrast, 
our data suggest that Blimp-1 could act as a molecular rheostat in CD8 T cells 
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during chronic infection, mediating different cell fates or transcriptional events at 
different expression levels.  Other transcription factors can function in a graded 
fashion, and some molecules that possess this property include master 
regulators of cell fate and differentiation such as Nanog, Sox2 and Oct-3/4 (206, 
207).  The transcription factor PU.1 also acts in a graded manner during 
hematopoietic differentiation (208). Accumulating evidence also points to the 
importance of quantitative changes in the expression of transcription factors such 
as Tbet and Eomes in memory CD8 T cell differentiation following acute infection 
(60, 148, 149).  The timing of conditional deletion also appears to have an impact 
on the functionality of exhausted CD8 T cells.  Conditional deletion prior to 
activation (CD4-Cre) results in poor viral control that is apparent by 1 month p.i., 
in contrast to deletion post-activation (gzmB-Cre), suggesting that Blimp-1 may 
be required upon activation to acquire even residual effector function.  Thus, our 
data on both temporal expression patterns and conditional deficiency suggest 
that low or intermediate expression of Blimp-1 is required for some effector 
functions and could be important in fate decisions between memory and terminal 
effector cell differentiation following acute infection, while overexpression of 
Blimp-1 promotes CD8 T cell exhaustion and represses memory differentiation.  
Our studies also point to a critical role for sustained cytolytic potential 
during chronic viral infections.  Recent work has demonstrated the importance of 
cytotoxicity in long-term control of chronic infections in humans (209-212).  While 
exhausted CD8 T cells are known to have partial defects in killing compared to 
highly functional effector or memory CD8 T cells (89), some residual cytotoxicity 
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by antigen-specific CD8 T cells can be maintained in vivo (213).  Blimp-1 
conditional het mice controlled virus substantially faster than either the wt or CKO 
mice, and this difference corresponded to sustained cytolysis in the conditional 
het mice compared to the CKO mice.  However, conditional het mice controlled 
virus in vivo more rapidly than wt mice as well, despite similar killing and cytokine 
production in vitro.  It is possible that lower PD-1 expression by conditional het 
mice may lead to improvements in effector function in vivo that are not obvious in 
vitro, as has been observed with blockade of other inhibitory pathways such as 
LAG-3 (160).  Conditional het mice also had slightly higher total numbers of 
antigen-specific CD8 T cells than wt mice including more DbNP396-specific CD8 
T cells.  Higher numbers of virus-specific CD8 T cells and improved effector 
functions in vivo by conditional het mice could account for this more efficient 
control of infection compared to wt mice, but future studies are necessary to 
investigate these issue further.  
In summary, we have identified Blimp-1 as a transcriptional regulator of 
functional exhaustion and repressor of memory differentiation in CD8 T cells 
during chronic viral infection. These studies provide a framework to begin 
dissecting Blimp-1 targets, regulation of Blimp-1 activity and additional 
transcriptional pathways involved in T cell dysfunction during chronic infection. 
While there are clearly additional transcription factors and transcriptional 
pathways that contribute to T cell exhaustion, our results identify Blimp-1 as a  
transcriptional regulator of CD8 T cell exhaustion during chronic viral infection. 
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Chapter 3 
Viral antigen and extensive division maintain virus-specific 
CD8 T cells during chronic viral infection 
 
Abstract 
Efficient maintenance of memory CD8 T cells is central to long-term 
protective immunity.  IL-7 and IL-15 driven homeostatic proliferation is essential 
for long-term memory CD8 T cell persistence following acute infections.  During 
chronic infections, however, virus-specific CD8 T cells respond poorly to these 
cytokines.   Yet, virus-specific CD8 T cells often persist for long periods of time 
during chronic infections.   We have addressed this apparent paradox by 
examining the mechanism for maintaining virus-specific CD8 T cells during 
chronic infection. We find that homeostatic cytokines (e.g. IL-7/15), inflammatory 
signals and priming of recent thymic emigrants are not sufficient to maintain 
virus-specific CD8 T cells over time during chronic infection.  Rather, our results 
demonstrate that viral peptide is required for virus-specific CD8 T cell persistence 
during chronic infection.  Moreover, this viral antigen-dependent maintenance 
results in a dramatically different type of T cell division than is normally observed 
during memory T cell homeostasis.  Rather than undergoing slow, steady 
homeostatic turnover during chronic viral infection, CD8 T cells undergo 
extensive peptide-dependent division, yet cell numbers remain relatively stable. 
These results indicate that antigen-specific CD8 T cell responses during 
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persisting infection are maintained by a mechanism distinct from that following 
acute infection. 
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Introduction 
 A cardinal property of memory CD8 T cells that differentiate after acute 
infection is their long-term, antigen-independent survival and self-renewal, which 
is driven by the homeostatic cytokines IL-7 and IL-15 (22).  The ability to respond 
to these homeostatic cytokines is a property that is gradually acquired as 
memory CD8 T cells differentiate (64), and is mediated by the upregulation IL-
7Rα (CD127) and IL-15Rβ (CD122) (22).  During chronic viral infection, 
expression of these receptors is impaired (14, 174, 176), and in vitro responses 
of IL-7 and IL-15 are poor (174, 180).  CD127 levels are also decreased on 
antigen-specific CD8 T cells during human chronic infections such as HIV  and 
HCV (14).  When transferred to naïve recipients, exhausted CD8 T cells that are 
‘rested’ in an infection-free environment do not adopt a memory phenotype (i.e. 
upregulate CD127 or CD62L) and slowly decline in number over time (174).  
Despite this, exhausted antigen-specific CD8 T cells persist long-term within the 
original chronically infected host (90, 174).  This suggests that the mechanism of 
maintenance utilized by exhausted antigen-specific CD8 T cells during chronic 
viral infection is very different from the cytokine-driven homeostasis of memory 
CD8 T cells after an acute infection. 
 Despite numerous observations that the IL-7 and IL-15 pathways are 
impaired during chronic viral infection, the exact mechanism by which exhausted 
CD8 T cells are maintained is unknown.  Several possibilities exist: 1) IL-7 and 
IL-15 may be expressed at a different level or different manner during chronic 
infection, 2) an unknown cytokine or growth factor present only during chronic 
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infection, 3) some unidentified cell-cell contact mediating survival, 4) the input of 
primed recent thymic emigrants (182) or 5) persistent antigen.  This chapter will 
explore these different possibilities to determine the signal(s) that are necessary 
to maintain exhausted CD8 T cells. 
 Our work from Chapter 2 shows that Blimp-1 may be a key factor in 
repressing memory differentiation during chronic viral infection.  In this chapter, 
we examine the consequences of altered memory differentiation and how 
homeostasis of the dysfunctional antigen-specific CD8 T cell population is 
impacted.  Our data indicate that IL-7 and IL-15 are not necessary in vivo for the 
persistence of these antigen-specific CD8 T cells during chronic viral infection.  
By using an adoptive transfer system with a variant LCMV clone 13 strain, we 
show that cognate antigen is required for the maintenance of virus-specific CD8 
T cells, and that primed RTEs do not have to join the existing pool of exhausted 
CD8 T cells to maintain stable numbers.  Furthermore, rather than undergoing 
the slow, steady homeostatic proliferation that is characteristic of memory CD8 T 
cells, exhausted CD8 T cells undergo rapid, antigen-driven division.  Thus, our 
study identifies a unique homeostatic mechanism of exhausted CD8 T cells and 
has implications for the maintenance of protective immunity during the treatment 
of chronic infections.    
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Materials and Methods 
Animals and viruses.  Four to six week old female C57BL/6 mice were 
purchased from the Jackson Laboratories, and four to six week old female 
congenic B6-Ly5.2/Cr mice were purchased from NCI.  Thymectomized and 
sham thymectomized C57BL/6 mice were purchased form Charles River 
Laboratories. IL-15-/- mice were originally obtained from Michael Caligiuri (Ohio 
State University, Columbus, OH).  Mice were infected with 2x106 plaque forming 
units (PFU) of LCMV clone 13 or the V35A clone 13 variant virus i.v. or 2x105 
PFU of LCMV Armstrong i.p. as described (89).  The V35A variant of LCMV 
clone 13 was isolated following infection of C57BL/6 mice containing LCMV-
specific TCR transgenic T cells (P14 cells).  Briefly, a small number of naïve P14 
splenocytes was adoptively transferred to C57BL/6 mice followed by LCMV clone 
13 infection.  Virus was isolated from viremic mice approximately 1 month post 
infection by plaque purification and sequenced through the GP33-41 encoding 
region.  Several clones were identified with the same Val to Ala mutation at 
residue 35, a mutation that has been previously observed (214).  Virus was 
grown and viral titers were determined by plaque assay as described (89).  The 
αIL-7Rα antibody was purified by the hybridoma core at the Wistar Institute from 
the supernatant of the A7R34 hybridoma and used as described (63).  All mice 
were used in accordance with institutional IACUC procedures. 
 
Lymphocyte isolation and flow cytometry.  Lymphocyte isolation from 
lymphoid and non-lymphoid tissues and surface and intracellular stains were 
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performed as previously described .  All antibodies were purchased from BD 
Biosciences except for CD127, Ly5.2 (eBioscience) and granzyme B (Caltag).  
APC-streptavidin was purchased from Invitrogen.  MHC class I peptide tetramers 
were made and used as described previously (89).   
 
CFSE labeling and adoptive transfers.  After wt clone 13 or V35A clone 13 
infected mice were no longer viremic (2-3 months post-infection), wt clone 13 
donor mice were sacrificed and their spleens were harvested.  CD8 T cells were 
purified from splenocytes using magnetic beads (MACS beads, Miltenyi Biotec).  
Briefly, splenocytes were labeled with magnetic beads specific for CD8α and 
then run through a MACS LS separation column (Miltenyi Biotec) according to 
the manufacturer’s protocol. The purified CD8 T cells were then labeled with 
CFSE as described previously (89, 174).  Purified CD8 T cells were adoptively 
transferred intravenously to each recipient mouse.  Between 2-2.5x105 DbGP33-
specific CD8 T cells were transferred in the experiments shown.  In each 
individual experiment identical numbers of DbGP33 tetramer+ CD8 T cells were 
adoptively transferred to each separate recipient mouse.  Donor populations 
were monitored in the peripheral blood by retro-orbital blood collection as 
described previously (174). 
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Results 
Exhausted CD8 T cells persist long-term despite low expression of homeostatic 
cytokine receptors. 
 After an acute infection, antigen-specific CD8 T cells expand into a pool of 
effector cells, undergo contraction and are subsequently stably maintained as a 
population of memory CD8 T cells in the absence of antigen (66) (Fig 14a).  To 
examine the persistence of exhausted antigen-specific CD8 T cells after a 
chronic viral infection, C57BL/6 mice were infected with either LCMV Armstrong 
(Arm) or LCMV clone 13, and the frequency of DbGP33-specific CD8 T cells was 
tracked in the blood.  The kinetics of the DbGP33-specific CD8 T cell response 
was similar between LCMV Arm and clone 13 infection, and like memory CD8 T 
cells in the Arm immune mice, exhausted CD8 T cells were stably maintained for 
approximately one year post infection (Fig 14a).   
 A key feature of memory CD8 T cells is their high expression of the 
homeostatic cytokine receptors CD127 and CD122 (22).  DbGP33-specific CD8 
T cells from Arm immune mice all expressed high levels of CD127 and CD122 in 
both lymphoid and non-lymphoid tissues (Fig 14b).  However, DbGP33-specific 
CD8 T cells from chronically infected mice expressed lower levels of both 
receptors as compared to memory CD8 T cells from the Arm immune mice (Fig 
14b).  The distribution of CD127 expression was much broader, with a significant 
fraction of the total population being CD127lo, and the MFI of CD122 expression 
was consistently lower on exhausted CD8 T cells than memory CD8 T cells in 
both lymphoid and non-lymphoid tissues (Fig 14b).  Thus, while antigen-specific 
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Figure 14.  Exhausted antigen-specific CD8 T cells persist but do not 
express high levels of homeostatic cytokine receptors.  A) Longitudinal
analysis of DbGP33+ CD8 T cells in the blood after LCMV Arm or clone 13 
infection.  N=3-9 per time point.  Error bars are SEM.  B) Analysis of CD127 and
CD122 expression on DbGP276+ CD8 T cells from tissues of Arm immune 
(>d30 p.i.) and clone 13 infected mice (2-4 months p.i.).  Histograms are gated
on DbGP276+ CD8 T cells from Arm immune (open) or clone 13 (shaded) 
infected mice.  Similar results were obtained for DbGP33+ CD8 T cells (not
shown).
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exhausted CD8 T cells persist long-term in chronically infected mice, they do not 
upregulate the expression of key homeostatic cytokine receptors. 
 
Exhausted CD8 T cells do not require IL-7 and IL-15 for long-term maintenance. 
 As memory CD8 T cells generated after an acute infection use IL-7 and IL-
15 for their long-term survival and self-renewal, we wanted to examine whether 
exhausted CD8 T cells, despite their low expression of CD127 and CD122, could 
also use these two cytokines in vivo for their maintenance.  To test this, IL-15-/- 
or wt mice were infected with LCMV Arm or clone 13.  Two to three months post-
infection, wt mice were left untreated, and IL-15-/- mice were treated with an 
antibody that blocks the interaction with IL-7 and IL-7Rα (A7R34).  This approach 
has been previously used to block IL-7 signals, including those necessary for 
memory CD8 T cell homeostasis (63, 127, 215, 216).  As expected, DbGP33-
specific CD8 T cells in the untreated Arm immune wt controls were stably 
maintained in the blood, while the frequency of DbGP33-specific CD8 T cells in 
the Arm immune IL-15-/- mice declined significantly after A7R34 treatment (Fig 
15a).  However, in mice infected with LCMV clone 13, there was no difference in 
the frequency of DbGP33-specific CD8 T cells between untreated wt and IL-15-/- 
mice treated with A7R34 (Fig 15a).  When compared directly, it was apparent 
that lack of signals from the IL-7 and IL-15 pathways had a much greater impact 
on the maintenance of antigen-specific memory CD8 T cells in Arm immune mice 
than exhausted CD8 T cells from chronically infected mice (Fig 15a).  We also 
observed a decrease in the number of memory DbGP33-specific CD8 T cells in 
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Figure  15.  Virus-specific CD8 T cells do not require IL-7 and IL-15 to
persist in chronically infected hosts.  A) IL-15 KO and wt mice were infected
with LCMV Arm or clone 13.  After 2-3 months p.i., the IL-15 KO mice were
treated with 200 υg αIL-7Rα antibody (Ab) i.p. every 2-3 days for 2 weeks, and 
the maintenance of virus-specific CD8 T cells was compared to untreated wt 
mice.  Left graph shows Arm-infected Ab treated IL-15 KO and untreated wt mice.
Middle graph shows clone 13-infected Ab treated IL-15 KO and untreated wt
mice.  Right graph displays a direct comparison of the same LCMV Arm and 
clone 13 infected Ab treated IL-15 KO groups from the first two graphs.  All 
graphs show DbGP33+ CD8 T cell frequency in the blood as a percentage of
the DbGP33+ CD8 T cell frequency on the first day of treatment (initial).  Graphs
represent three independent experiments, n=8-11 per time point.  *p<0.05 by 
Student’s t-test. Error bars are SEM. B) Absolute number of DbGP33+ CD8 T 
cells in the spleens of LCMV Arm immune and clone 13 infected wt untreated and 
IL-15 KO Ab treated mice at the end of treatment.  Graphs represent two 
independent experiments, n=8-10 per group.  *p=0.03 by Student’s t-test.  Error 
bars are SEM.
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the spleens of Arm immune IL-15-/- mice treated with A7R34, but not in those 
infected with LCMV clone 13 (Fig 15b).  Thus, unlike memory CD8 T cells 
generated after an acute infection, exhausted CD8 T cells present after a chronic 
infection do not depend on the homeostatic cytokines IL-7 and IL-15 for their 
long-term maintenance in vivo. 
 
Recent thymic emigrants are not required for the maintenance of an antigen-
specific CD8 T cell population. 
 As IL-7 and IL-15 do not appear necessary for the long-term persistence 
of the exhausted antigen-specific CD8 T cell population, it appears that another 
mechanism is being engaged.  As exhausted CD8 T cells that are adoptively 
transferred to naïve recipients decline in number over time (174), it is likely that a 
factor unique to the environment of chronic viral infections is providing the 
maintenance signal.  One possibility is that recent thymic emigrants (RTEs) are 
being primed by persisting antigen and joining the pre-existing pool of antigen-
specific CD8 T cells.  Previous findings using thymectomized mice suggest that 
recent RTEs are not required for the maintenance of an antigen-specific CD8 T 
cell population (181).  However, Vezys et al showed that thymic emigrants can 
be primed by persisting antigen during both chronic LCMV and polyoma virus 
(PyV) infection, and that RTEs were necessary for the stable maintenance of 
PyV-specific CD8 T cells (182).  Also, the primed thymic emigrants contributed to 
the dynamic phenotype of the total antigen-specific CD8 T cell population (182).  
Thus, in order to determine whether thymic emigrants contribute to the 
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maintenance of virus-specific CD8 T cells during chronic LCMV infection, 
thymectomized, sham thymectomized or intact B6 (control) mice were infected 
with LCMV clone 13 and the virus-specific CD8 T cell response was tracked over 
time.  The frequency of DbGP33-specific CD8 T cells in the thymectomized mice 
was very similar to frequencies in either the intact B6 (exp 1) or the sham 
thymectomized mice (exp 2) (Fig 16a).  The absolute number of virus-specific 
CD8 T cells in the spleens of thymectomized and control mice was nearly 
indistinguishable for the three epitopes tested, and the number of DbGP33-
specific CD8 T cells in the liver and BM of the two groups was also very similar 
(Fig 16b).  To test whether the lack of RTEs in the thymectomized mice had an 
impact on the overall phenotype of the antigen-specific CD8 T cell population, we 
analyzed the expression of several different markers associated with mature 
memory CD8 T cells (137).  We found no significant difference between the 
thymectomized and control mice in CD127, CD62L, CD43 or CXCR3 expression 
(Fig 16c).  There was also no difference in the ability of virus-specific CD8 T cells 
to produce antiviral cytokines upon in vitro stimulation (data not shown).  Thus, in 
the LCMV model system, while RTEs can be primed by persistent antigen as 
shown by Vezys et al, they are not necessary for the long-term maintenance of 
an exhausted antigen-specific CD8 T cell population.  
 
Variant LCMV clone 13 virus does not elicit a DbGP33-specific CD8 T cell 
response. 
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Figure 16.  Thymic output is not necessary for the maintenance of virus-
specific CD8 T cells during chronic LCMV infection.  Thymectomized (thx), 
sham thymectomized or unmanipulated B6 (ctrl) mice were infected with LCMV 
clone 13 and CD8 T cells were analyzed ~3 months p.i. unless otherwise noted.  
A) Frequency of DbGP33+ CD8 T cells in the blood of thx, sham or ctrl mice at 
the indicated time points.  N=2-5 per time point.  Error bars are SEM.  B) Absolute
number of antigen-specific CD8 T cells in thx or ctrl mice.  Number of antigen-
specific CD8 T cells was measured in the indicated tissues.  N=2 per group.  
Error bars are SEM.  C) Phenotype of antigen-specific CD8 T cells in thx or ctrl
mice.  Plots are gated on total CD8 T cells from the spleen.  Numbers in plots
indicate percent of DbGP33+ CD8 T cells that are positive for each marker.  
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 To examine the mechanism by which antigen-specific CD8 T cells persist 
during chronic viral infection, we used a variant strain of LCMV clone 13 with a 
mutation in the GP33 epitope (V->A mutation at residue 35, V35A).  This 
mutation in the epitope abolishes binding of the GP33 epitope to Db MHC class I 
molecules (214).  Infection with the V35A virus establishes a chronic infection 
with viremia that is nearly identical to wt clone 13 (Fig 17a).  Unlike wt clone 13, 
infection with the V35A virus does not generate a DbGP33-specific response, 
although responses to four other epitopes were similar (Fig 17b). 
 To test whether the V35A virus could stimulate memory DbGP33-specific 
CD8 T cells, CD8 T cells were purified from the spleens of Arm immune mice, 
CFSE labeled and adoptively transferred to mice infected with V35A after the 
control of viremia (~2 months p.i.).  The donor DbGP33-specific CD8 T cells 
failed to expand, and rather appeared to undergo division that was reminiscent of 
the slow, steady homeostatic proliferation that is characteristic of resting memory 
CD8 T cells (22) (Fig 17c,d).  Donor memory CD8 T cells specific for the 
DbGP276 epitope, however, proliferated extensively upon adoptive transfer to 
V35A infected recipients, and the majority of the population became CFSE 
negative (Fig 17c,d).  Thus, infection with V35A causes a chronic viral infection 
with viral titers that are similar to wt LCMV clone 13.  Furthermore, while the 
mutated GP33 epitope in the V35A virus is does not activate a naïve or memory 
GP33-specific response, other epitopes can generate CD8 T cell responses that 
are similar to wt LCMV clone 13. 
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Figure 17.  The V35A clone 13 variant virus causes chronic infection similar
to wt clone 13.  B6 mice were infected with wt or V35A variant clone 13.
A) Viral load was determined in the blood of mice infected with wt or V35A variant
clone 13 by plaque assay.  Dashed line shows limit of detection.  Error bars are 
SEM.  B) Tetramer staining of splenocytes on day 8 p.i.  Plots are gated on total
CD8 T cells.  Numbers in plots show percent of CD8 T cells positive for each 
tetramer.  C) CD8 T cells from Arm immune (>d30 p.i.) were adoptively 
transferred into V35A-infected Ly5.1+ B6 mice (~2-7 months p.i.).  Donor Ly5.2+
DbGP276+ and DbGP33+ CD8 T cells were monitored in the blood.  Kinetics of
expansion were normalized to number at d5 post-transfer.  N=3-4 per time point.
Data are representative of two independent experiments.  Error bars are SEM.  
D) CFSE profiles are shown for the donor (Ly5.2+) DbGP33+ and DbGP276+ 
CD8 T cells in V35A-infected recipients 3 weeks post-transfer for the experiment 
in part C.  Plots are gated on donor Ly5.2+ CD8 T cells.  Histograms are gated 
on donor tetramer+ CD8 T cells.  Numbers over gates in the histograms show 
percent of cells that are CFSE-.  Data are representative of two independent 
experiments. 
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Cognate virus-derived antigen is required for the maintenance of antigen-specific 
CD8 T cell during chronic viral infection. 
 In order to determine the factor(s) that could be providing the maintenance 
signal to exhausted antigen-specific CD8 T cells, the V35A virus was used to 
narrow the possibilities to either antigen or some other factor present in the 
chronically infected environment.  An adoptive transfer system was used in which 
Ly5.2+ donor mice were infected with wt LCMV clone 13, and Ly5.1+ recipient 
mice were infected with either wt LCMV clone 13 or V35A virus, all at the same 
time (Fig 18a).  After all three groups controlled viremia (~2-3 months p.i.), CD8 T 
cells were purified by magnetic beads from the spleens of the donor wt LCMV 
clone 13 infected mice, and equal numbers of DbGP33-specific CD8 T cells were 
transferred to all recipient mice (Fig 18a).  This strategy allowed us to compare 
the maintenance of the donor DbGP33-specific population in recipient mice 
where cognate antigen is either present or absent.  A donor population of 
DbGP33-specific CD8 T cells was present and measurable at both early and late 
time points post transfer, as was a control population of donor DbGP276-specific 
CD8 T cells (Fig 18b).  As a second strategy, by tracking both donor populations 
in the same V35A infected recipient mouse, we could internally control any 
variability between different recipients. 
 When donor DbGP33-specific CD8 T cells were transferred to wt LCMV 
clone 13 infected recipients, the population was stably maintained over time (Fig 
18c).  However, when transferred to a recipient infected with V35A, the frequency 
of the donor DbGP33-specific population decreased over time (Fig 18c).  
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Figure 18.  Virus-specific CD8 T cells from chronically infected mice do not
persist without cognate antigen.  A) Experimental schematic.  Donor Ly5.2+ B6 
mice were infected with wt clone 13, and recipient Ly5.1+ B6 mice were infected 
with either wt or V35A clone 13 on the same day.  2-3 months later, CD8 T cells 
were purified from the spleens of donor Ly5.2+ mice using magnetic beads and 
equal numbers of DbGP33+ CD8 T cells were transferred to the recipients. 
B) Representative analysis of DbGP33+ and DbGP276+ donor Ly5.2+ CD8 T 
cells in the blood of recipient mice.  Numbers are the percent of donor CD8 T 
cells that are tetramer+.  C) Frequency of DbGP33+ donor cells in the blood of
wt and V35A clone 13 infected recipients.  At the last time point, wt vs V35A 
*p=0.008 by Student’s t-test.  Graph is representative of two independent
experiments.  D) Frequency of DbGP33 and DbGP276+ donor CD8 T cells in the
blood of V35A clone 13 infected recipients.  Difference between DbGP33+ and 
DbGP276+ frequency is significant at indicated time points (p<0.05 by Student’s
t-test).  Graph is representative of five independent experiments, n=2-3 per group.
E)  Number of donor tetramer+ CD8 T cells in  indicated tissues of V35A-infected
recipients.  BM represents two femurs.  Graphs represent 2-3 independent 
experiments, n=3-6 per group.  *p<0.04 by Student’s t-test. Error bars are SEM.     
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Furthermore, within the same V35A infected recipient, while the donor DbGP33-
specific population slowly declined in the absence of specific peptide, the donor 
DbGP276-specific CD8 T cells persisted (Fig 18d).  The disappearance of donor 
DbGP33-specific CD8 T cells was not simply due to a migration of these cells out 
of the blood, as the number of donor DbGP33-specific CD8 T cells was lower in 
both lymphoid and non-lymphoid tissues such as the spleen, liver and bone 
marrow (Fig 18e).  Together, our data suggest that virus-derived cognate antigen 
is the signal that is necessary to maintain a long-term population of antigen-
specific CD8 T cells during chronic viral infection. 
 
Virus-specific CD8 T cells are maintained by rapid, antigen-driven division during 
chronic viral infection. 
Following an acute infection, memory CD8 T cells undergo a slow, steady 
homeostatic proliferation to mediate their survival and self-renewal (22).  As the 
signal that maintains antigen-specific CD8 T cells during chronic viral infection is 
very different from that of memory CD8 T cells, we next wanted to determine 
whether the virus-specific CD8 T cells underwent a similar type of division.  As a 
control, CD8 T cells from the spleens of Arm immune mice were isolated, labeled 
with CFSE and transferred to naïve, congenically marked recipients.  As 
expected, the antigen-specific memory CD8 T cells underwent typical 
homeostatic proliferation, where only a portion (~50%) of the population divided 
no more than 5 times over the course of four weeks (Fig 19a,c,d).  In order to 
examine division during chronic viral infection, an adoptive transfer system 
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Figure 19.  Virus-specific CD8 T cells are maintained by extensive
proliferation during chronic infection.  The experimental approach from Fig
18a was used to monitor cell division history of CFSE labeled donor cells during 
chronic LCMV infection.  A) Prolferation patterns of donor virus-specific CD8 T 
cells in the blood.  Left column shows homeostatic proliferation of memory CD8 T 
cells from Arm immune mice (>d30 p.i.) after adoptive transfer to naive mice.  
Middle column shows division of DbGP33+ CD8 T cells in V35A-infected 
recipients (without antigen).  Right column shows division of DbGP276+ CD8 T 
cell population from same V35A recipient (with antigen).  B) Proliferation of wt 
clone 13-derived donor virus-specific CD8 T cells in the liver of V35A-infected
recipients at 4 weeks post-transfer.  C) Histograms of donor tetramer+ CD8 T 
cells in the blood at 4 weeks post-transfer.  Numbers indicate the percent of
virus-specific CD8 T cells that have undergone no division (right gate), 1-5
divisions (middle) or 6+ divisions (left).  All histograms are gated on Ly5.2+ CD8
tetramer+ populations.  D) Graphs indicate percent of donor tetramer+ CD8 T 
cells that have undergone 0, 1-5 or 6+ divisions.  Top row is from the blood, 
bottom is from the spleen at 4 weeks post-transfer.  Error bars are SEM.  Data
is representative of 2-4 independent experiments.
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identical the one previously described (Fig 18a) was used with CFSE labeled 
donor CD8 T cells.  Briefly, Ly5.2+ donor mice were infected with wt LCMV clone 
13, and Ly5.1+ recipient mice were infected with V35A.  After control of viremia, 
CD8 T cells were purified from the spleens of the donor mice, CFSE labeled and 
adoptively transferred to the recipient mice.  The donor populations were tracked 
in the blood both in the presence (DbGP276) and absence (DbGP33) of cognate 
antigen.  Over the course of four weeks, the donor DbGP33-specific CD8 T cell 
population did not appear to undergo any sort of division in the absence of 
antigen, and indeed, declined in frequency over time (Fig 19a,c,d).  However, 
when the donor DbGP276-specific CD8 T cell population was examined, the 
pattern of division presented was strikingly different from that of memory CD8 T 
cells.  Donor DbGP276-specific CD8 T cells transferred to recipients chronically 
infected with V35A virus did not divide during the first two weeks post transfer 
(Fig 19a).  However, in the third week post transfer, a small population of CFSE 
negative donor DbGP276-specific CD8 T cells appeared, and this CFSE negative 
population increased in the fourth week (Fig 19a,c,d).  This was in stark contrast 
to the homeostatic proliferation of memory CD8 T cells, were no cells fully diluted 
CFSE over the course of four weeks (Fig 19a,c,d).  This rapid, antigen-driven 
division was not isolated to the blood, as it was also observed in the spleen and 
liver (Fig 19b,d).  In sum, our data suggest that during chronic viral infection, 
antigen-specific CD8 T cells are maintained by a mechanism of rapid proliferation 
that is driven by specific, virus-derived peptide rather than cytokine-driven 
homeostatic proliferation. 
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Discussion 
In this chapter, we have defined the mechanism of virus-specific CD8 T 
cell maintenance during chronic viral infection and have also uncovered a 
division pattern that is distinct from the homeostatic turnover of memory T cells.  
Our studies indicated that viral antigen was necessary for long-term persistence 
of virus-specific CD8 T cells during chronic infection, and also that the 
environment of chronic infection, including any inflammatory signals and altered 
IL-7 and IL-15 expression, was not sufficient to maintain virus-specific CD8 T 
cells in chronically infected mice.  It remains possible that environmental factors 
may play an accessory role, but they alone cannot sustain virus-specific CD8 T 
cells during chronic LCMV infection.   
During chronic LCMV infection, many virus-specific CD8 T cells had 
divided more than 5-6 times in ~1 month in the presence of viral antigen, yet the 
number of these virus-specific CD8 T cells numbers remained relatively stable.  
This observation suggests that either a very small subset of CFSEhi cells are 
recruited to divide or that the antigen-driven division of this CD8 T cell population 
is accompanied by extensive cell death.  This pattern of division may help explain 
the immunodominance changes and the immune “inflation” that has been 
observed during several persisting infections (89, 217, 218).  A difference 
between death and division rates during homeostatic proliferation following acute 
infection may lead to only a subtle change in cell numbers since the rate of 
division is slow.  In contrast, during chronic infection, where the persisting virus-
specific CD8 T cell population undergoes extensive division over the course of 
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several weeks, a minor discrepancy between the rates of division and death 
could be amplified to a large change in cell numbers.  Therapeutic manipulation 
of the rate of either recruitment into division or death may provide a novel means 
to modulate antigen-specific CD8 T cell responses to persisting viral antigen.   
The CFSE profiles in the present study reveal populations of both 
extensively divided and completely undivided virus-specific CD8 T cells during 
persisting infection.  It is unclear why some virus-specific CD8 T cells proliferate 
extensively during chronic infection while others did not.  The transfer of memory 
CD8 T cells from Arm immune mice to chronically infected recipients results in 
complete division of all DbGP276-specific donor cells (see Figure 2).  This 
observation suggests that lack of antigen encounter is an unlikely explanation for 
the undivided population of virus-specific CD8 T cells from chronically infected 
mice.  A second possibility is that only a subpopulation of the virus-specific CD8 
T cells generated during chronic infection are capable of the peptide-dependent 
division.  It will be important to determine whether heterogeneity exists in these T 
cell populations based on antigen-dependent maintenance potential or division 
history. 
The present study suggests that during chronic infections, virus-specific 
CD8 T cells acquire a mechanism of maintenance distinct from naïve CD8 T cells 
or effector and memory CD8 T cells generated following acute infection.  During 
chronic infection, virus-specific CD8 T cells appear to rely on TCR signals for 
persistence.  However, unlike naïve CD8 T cells, MHC and self-peptide alone 
cannot supply the TCR signal required by virus-specific CD8 T cells during 
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chronic infection.  Instead, viral antigen is necessary for long-term persistence.  
Unlike memory CD8 T cells that undergo proliferative expansion in response to 
antigen, virus-specific CD8 T cells present during chronic infection undergo 
extensive division, but the population does not expand dramatically in number in 
response to low levels of persisting viral antigen (compare the DbGP276 
response in Figure 17c and 18d).  Whether all virus-specific CD8 T cells undergo 
this antigen-driven division, or only a small subset of cells are recruited to divide, 
the observations are consistent with previous studies that found reduced 
proliferative potential of virus-specific T cells during chronic infection (89, 174, 
210).  This altered responsiveness to homeostatic signals and to persisting viral 
antigen suggests that during chronic infections, virus-specific CD8 T cells 
undergo a fundamentally different pattern of differentiation compared to memory 
CD8 T cells that develop in the absence of persisting antigen following acute 
infection.  Thus, during chronic viral infection, antigen-specific CD8 T cells 
appear to be “tuned” to respond to low levels of antigen in a dramatically different 
manner than memory CD8 T cells generated following acute infections.  
A recent study suggested that ongoing thymic output can result in priming 
of new virus-specific CD8 T cells during persisting infections (182).   In the 
current study, we found that chronic infection of thymectomized mice did not 
have a significant impact on the maintenance, function or phenotype of the 
antigen-specific CD8 T cell population.  We also used congenically marked donor 
populations and found that the number of tetramer+ CD8 T cells remains 
reasonably stable for ~10 weeks when antigen is present (see Figure 18).  These 
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results suggest that RTEs are not necessary to maintain a virus-specific CD8 T 
cell population during chronic LCMV infection.  However, our results do not 
exclude a qualitative contribution from RTEs primed on persisting antigen in the 
periphery.  It will be interesting to determine if a subpopulation of recently primed 
CD8 T cells possesses distinct functional characteristics compared to the 
majority of the antigen-specific population that has been maintained since early 
during the initial infection.  
In summary, the present work defines specific viral antigen, rather than IL-
7 and IL-15, inflammatory cytokines or new recruitment from RTEs, as an 
essential signal that governs the persistence of virus-specific CD8 T cells during 
chronic LCMV infection in mice.  In addition, we have identified a new 
mechanism for this type of antigen-dependent, long-term persistence by 
extensive cellular division without dramatic changes in cell numbers.  These 
observations may provide a framework to re-evaluate a long-standing debate 
about the role of persisting antigen in the maintenance of immunological 
memory.  Finally, the antigen-dependent maintenance mechanism described in 
this study may have implications for therapeutic interventions if either the rate of 
proliferation or cell death can be modulated in vivo to alter the size or quality of 
antigen-specific CD8 T cell populations during persisting infections.   
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Chapter 4 
A role for chronic inflammation in the regulation of CD8 T cell 
dysfunction during chronic infection 
 
Abstract 
Chronic infections represent a major social and economic problem around 
the world.  The control of disease burden can be further complicated by the co-
infections and secondary infections that accompany many chronic infections.  
Epidemiologically, chronic infections have been shown to have a negative impact 
on the control of secondary infections or co-infections.  However, there is little 
understanding as to how established chronic infections impact cellular responses 
to heterologous infections.  CD8 T cell exhaustion and failed memory 
differentiation are features that are shared by many chronic infections and may 
contribute to poor pathogen control and diminished protective immunity.  The 
factors that regulate altered memory CD8 T cell differentiation during chronic 
infection are not well understood.  In this study, we examine the impact of 
prolonged inflammation on CD8 T cell differentiation and find that effector CD8 T 
cells differentiating to memory are more sensitive to alteration by chronic 
inflammation than established memory CD8 T cells.  Furthermore, memory CD8 
T cells that differentiate in the presence of persistent inflammation have poor 
secondary responses and provide less protection.  Together, these data suggest 
that established, persistent inflammation can impact memory differentiation in a 
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bystander fashion, and may lead to decreased efficacy of preventative 
vaccination strategies and diminished immunity to heterologous pathogens 
during chronic infection. 
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Introduction 
 After an acute infection, memory differentiation occurs in the absence of 
antigen, but also in the absence of any factors generated by host-pathogen 
interactions (14).  However, during chronic infection, altered memory 
differentiation occurs not only in the presence of persistent antigen, but also in 
the continuous presence of all factors that arise from host-pathogen interactions 
(i.e. cytokines, chemokines, TLR ligands, etc.), which will heretofore be referred 
to as ‘inflammation’.  While the role of persistent antigen has been well described 
in regulating functional exhaustion (89, 219), the role that inflammation plays has 
not been as well studied.  Recently, some of these factors, including the 
immunoregulatory cytokine IL-10 (183, 184) and IL-21 (186-188), have been 
shown to play an important role in determining the chronicity of LCMV infection 
and the functionality of the responding CD8 T cells.  However, it is not entirely 
clear from these studies whether the impact on the cellular response is due to 
altered pathogenesis of the infection, or due to the direct effect of these cytokines 
on the T cells themselves.  In this chapter, we investigate the impact that chronic 
‘inflammation’ has on the differentiation of dysfunctional T cells during chronic 
infection at two stages – the effector to memory transition, and the TEM to TCM 
transition. 
  In addition to providing a greater understanding of how functional 
exhaustion is regulated during chronic infection, these studies could have 
important implications for understanding the biology of co-infections.  There is a 
considerable amount of epidemiological evidence that suggests that chronic 
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infections, even those that are not overtly immunosuppressive such as HIV, can 
have a negative impact on responses to secondary, heterologous infections.  
Malaria infections are associated with increased HIV viral loads, particularly 
during febrile episodes (220), leading to increased transmission and thousands 
of additional cases of HIV infection (221).  Infection with helminths such as 
schistosomes may also lead to increased viral replication of patients co-infected 
with HIV (222).  Even in situations where a chronic infection is not involved, co-
infection can have a negative impact on secondary infections.  For example, 
acute respiratory infections such as influenza and RSV and other viral infections 
such as measles can lead to increased incidences of bacterial co-infections (223, 
224).  Furthermore, these bacterial infections often become more severe and 
lead to the onset of bacterial sepsis (224).  While co-infections and their impact 
on disease control have been well documented, there is little understanding of 
how established chronic infection affects the development of cellular responses 
to heterologous infections.   
 The two previous chapters examined cell-intrinsic regulation and cell-
intrinsic properties of functionally exhausted CD8 T cells.  In this chapter, we 
address the effect that cell-extrinsic factors generated by interaction of the host 
and pathogen has on the regulation of T cell dysfunction.  We find that chronic 
inflammation has a profound impact on the differentiation of memory CD8 T cells.  
Non-LCMV-specific CD8 T cells adoptively transferred to chronically infected 
recipients did not acquire several key memory properties.  However, some 
features that are normally associated with functional exhaustion, such as the 
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upregulation of inhibitory receptors, were not impacted by inflammation alone.  
Our results suggest that distinct aspects of T cell dysfunction may be regulated 
by different signals.  We believe that our study furthers our understanding of how 
functional exhaustion is regulated during chronic infections.  Furthermore, our 
results could have important implications when designing treatment strategies to 
control disease burden, particularly for those involving prophylactic or therapeutic 
vaccination of chronically infected patients. 
 
 
 
Materials and Methods 
Animals and viruses.  Four to six week old female C57BL/6 mice and four to six 
week old female congenic B6-Ly5.2/Cr  were purchased from NCI.  OTI TCR Tg 
mice were obtained from Wolfgang Weninger (Sydney Medical School, 
Australia).  Vesicular stomatitis virus recombinantly expressing OVA (VSV-OVA) 
was propogated and titered as previously described (125).  Listeria 
monocytogenes recombinantly expressing OVA (LM-OVA) was also propogated 
and titered as previously described (225).  ME-49 strain of Toxoplasma gondii 
(toxo) was obtained from David Roos, and was grown and titered as previously 
described (226).  LCMV virus was grown and titers were determined by plaque 
assay as previously described (89).  Mice were infected with 2x105 plaque 
forming units (PFU) i.p. of LCMV Armstrong, 2x106 PFU i.v. of LCMV clone 13, 
2x106 PFU i.v. of VSV-OVA, 1.5x104 colony forming units (CFU) i.v. of LM-OVA 
for primary challenges or 100 parasites i.p of toxo.  Secondary challenges were 
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performed with 2.5-5x105 CFU i.v. of LM-OVA.  All animals were used in 
accordance with IACUC procedures. 
 
Lymphocyte isolation and flow cytometry. Lymphocyte isolation from 
lymphoid and non-lymphoid tissues, surface stains and intracellular cytokine 
stains were performed as described previously (89).  All antibodies were 
purchased from Biolegend except for CD127, TNFa, IL-2 (eBioscience), CD62L 
(Invitrogen).  LIVE/DEAD dead cell stain was purchased from Invitrogen.  MHC 
class I tetramers were made and used as described previously (89).  All flow 
cytometry data was acquired on an LSRII (BD Biosciences) and analyzed by 
FlowJo (Treestar).   
 
Adoptive transfers. Naïve OTI TCR Tg mice were sacrificed and spleens were 
harvested.  5x105 splenocytes were adoptively transferred i.v. into congenically 
marked B6-Ly5.2/Cr naïve recipient mice.  Recipients were infected with an OVA 
expressing pathogen and were sacrificed 8-30 days post infection (p.i.).  Spleens 
were harvested, and CD8 T cells were purified by magnetic beads (MACS beads, 
Miltenyi Biotec).  Briefly, splenocytes were incubated with beads specific for 
CD8a and then run through a MACS LS separation column (Miltenyi Biotec) 
according to the manufacturer’s protocol.  Frequency of OTI CD8 T cells was 
determined by flow cytometry.  Equal numbers of OTI CD8 T cells were 
adoptively transferred to either infected or naïve congenically marked B6-
Ly5.2/Cr recipients.  Donor populations were monitored by retro-orbital bleeding 
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as described previously (174).  The same adoptive transfer method was used for 
secondary challenges.   
 
 
 
Results 
Established chronic infections alter CD8 T cell differentiation after heterologous 
challenge. 
In order to determine the role of chronic inflammation in regulating 
memory CD8 T cell differentiation, we first employed a direct co-infection model.  
Mice were infected with LCMV clone 13 and allowed to rest for 30 days.  At d30 
p.i., the LCMV clone 13 infected mice and naïve controls were infected with 
Listeria monocytogenes expressing recombinant OVA protein (LM-OVA).  
Response to the OVA peptide SIINFEKL was tracked over time and analyzed at 
30 days post LM-OVA challenge (Fig 20a).  As the LM-OVA is cleared within a 
week and the SIINFEKL epitope is not expressed by LCMV, we could be 
confident that the antigen-specific CD8 T cells responding to SIINFEKL would be 
differentiating in the absence of persistent antigen but in the presence of the 
chronic inflammation generated by LCMV clone 13 infection.  30 days after LM-
OVA challenge, the KbSIINFEKL-specific CD8 T cells in the control mice had 
differentiated into a population of memory CD8 T cells uniformly expressing high 
levels of CD127, and with a small subset beginning to upregulate CD62L (Fig 
20b).  In contrast, the KbSIINFEKL-specific population in the LCMV clone 13 co-
infected mice expressed low levels of CD127 and very few cells were CD62Lhi 
(Fig 20b).  When the effector function of these cells was assessed, we found that 
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Figure 20.  Chronic viral infection alters immune response to heterologous 
challenge.  A) Schematic of experiment.  B6 mice were infected with LCMV 
clone 13.  30 d.p.i., LCMV clone 13 infected mice and naive B6 were challenged 
with LM-OVA.  The OVA-specific response was analyzed 30 days after LM-OVA 
challenge.  B) Phenotype of OVA-specific CD8 T cells in ctrl and clone 13 
infected mice.  Plots are gated on total CD8 T cells.  Histograms are gated on 
OVA-specific CD8 T cells.  Numbers in plots show percent of total CD8 T cells 
that are OVA-specific.  Numbers in histograms show percent of OVA-specific CD8 
T cells that are positive for each marker.  C) Effector function of OVA-secific CD8 
T cells.  Splenocytes were stimulated with OVA peptide for 5 hrs at 37C.  All plots 
are gated on total CD8 T cells.  Number in plot shows percent of total CD8 T cells 
that produce IFNγ.  Graphs indicate percent of of IFNγ+ CD8 T cells that also 
produce the second indicated cytokine.  D) Number of OVA-specific CD8 T cells.  
Top graph shows frequency of OVA-specific CD8 T cells in the blood at the 
indicated time points.  Bottom graphs show absolute number of OVA-specific 
CD8 T cells in each indicated tissue.  Error bars are SEM.  N=5 at each time 
point.
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90-95% of the memory KbSIINFEKL-specific CD8 T cells in the control mice 
were capable of co-producing IFNγ and TNFα, and a substantial fraction 
expressed both IFNγ and IL-2 (Fig 20c).  In the LCMV clone 13 co-infected mice, 
however, while IFNγ and TNFα co-production appeared to be intact, IL-2 
production, a key memory property, was impaired (Fig 20c).  The frequency of 
KbSIINFEKL-specific CD8 T cells in the blood also differed between the control 
and LCMV clone 13 co-infected mice.  The peak of the antigen-specific CD8 T 
cell response in the LCMV clone 13 co-infected mice was slightly delayed and 
not as great as in the control mice (~d8 p.i.), although the frequency of 
KbSIINFEKL-specific CD8 T cells in the blood after the contraction phase was 
similar (~d30 p.i.) (Fig 20d).  The absolute number of KbSIINFEKL-specific CD8 
T cells was not significantly different in the spleen or liver between the two 
groups, though there was a trend towards fewer antigen-specific CD8 T cells in 
the spleens of the LCMV clone 13 co-infected mice and more in the liver (Fig 
20d).  Together, these results indicate that an established chronic viral infection 
can effect the differentiation of CD8 T cells responding to a heterologous 
infection by repressing the memory development and decreasing the magnitude 
of the effector response. 
 
Inflammation alone can repress memory CD8 T cell differentiation during chronic 
viral infection. 
 While the results from the direct co-infection model indicate that an 
established chronic viral infection can alter the CD8 T cell response to a 
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heterologous infection, a number of caveats complicate the interpretation of the 
data.  Co-infections can change the pathogenesis of both infections (220, 221, 
227) and LCMV clone 13 can infect APCs such as macrophages and DCs (87, 
88), which raises the possibility that antigen-presentation and activation of the 
KbSIINFEKL-specific CD8 T cells may not be normal.  To isolate the impact of 
chronic inflammation and focus directly on the memory differentiation stage, we 
switched to an adoptive transfer model.  5x105 OTI splenocytes were transferred 
to naïve recipients and challenged with vesicular stomatitis virus expressing the 
OVA protein (VSV-OVA).  At d8 p.i., CD8 T cells from the spleens of the infected 
OTI peripheral chimeras were purified and equal numbers of effector OTI CD8 T 
cells were transferred to control Ly5.1+ recipients that were either naïve or 
infected with VSV-OVA,  and to Ly5.1+ recipients that had been challenged with 
LCMV clone 13 8 days prior (Fig 21a).  Little difference was observed regardless 
of whether naïve or VSV-OVA infected recipients were used as controls.  At d8 
p.i., the effector OTI donor cells were mostly CD127lo and CD62Llo (Fig 21b).  By 
adoptively transferring an effector OTI CD8 population generated by an acute 
infection, we could ensure that the OTI CD8 T cells had been properly primed 
and were capable of differentiating into normal memory CD8 T cells.   
 After about one month post-transfer, the donor OTI CD8 T cells that had 
been adoptively transferred to the control recipient mice expressed high levels of 
CD127, and were beginning to upregulate CD62L (Fig 21c).  As in the direct co-
infection model, however, the donor OTI CD8 T cells transferred to the LCMV 
clone 13 infected recipients remained CD127lo and CD62Llo (Fig 21c).  Effector 
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Figure 21.  Memory CD8 T cell differentiation is repressed by chronic 
inflammation.  A) Schematic of experiment.  5x105 OTI splenocytes were 
adoptively transferred to naive B6 recipients.  Mice were challenged with 
VSV-OVA and one group of Ly5.1+ B6 recipients were infected with LCMV clone 
13 at the same time.  Control Ly5.1+ B6 mice were either challenged with 
VSV-OVA, LCMV Arm or naive.  No difference was observed between different 
controls.  At d8 p.i.,CD8 T cells were purified by magnetic beads from the spleens 
of the donor mice and equal numbers of OTI CD8 T cells were transferred to 
LCMV clone 13 infected and ctrl recipients.  Donor OTI CD8 T cells were 
analyzed ~1 month post-transfer.  B) Phenotype of donor OTI CD8 T cells pre-
transfer.  Plot is gated on total CD8 T cells.  Histograms are gated on OTI CD8 T 
cells.  Number in plot is percent of total CD8 T cells that are KbSIINFEKL+.  
Numbers in histograms show the percent of the OTI CD8 T cell population that is 
positive for each marker.  C) Phenotype of donor OTI CD8 T cells in the spleen 1 
month post-transfer.  Plots are gated on total CD8 T cells, histograms are gated 
on donor OTI CD8 T cells.  Numbers in plots indicate the percent of total CD8 T 
cells that are donor OTI.  Numbers in histograms show percent of donor OTI 
population that is positive for each marker.  Numbers are graphed to the right.  
N=2 per group, data is representative of seven independent experiments.  Error
bars are SEM.  (Figure continued on next page.)          
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Figure 21 (cont.).  Memory differentiation is repressed by chronic 
inflammation.  D) Effector function of donor OTI CD8 T cells.  Splenocytes were
stimulated with OVA peptide for 5 hrs at 37C.  Left plots are gated on total CD8
T cells, middle and right plots are gated on donor CD8 T cells.  Number in left
plots show percent of total CD8 T cells that produce IFNγ after OVA stim.  
Numbers in middle and left plots show percent of IFNγ+ CD8 T cells that also
produce the second indicated cytokine.  Numbers are graphed below.  N=2 per
group, data is representative of seven independent experiments.  Error bars are
SEM.  E) Number of OTI CD8 T cells in clone 13 infected or ctrl recipients.  
Frequency of donor OTI CD8 T cells was measured in the blood at the indicated
time points.  Absolute number of donor OTI CD8 T cells was measured in the 
indicated tissues.  Numbers above bar graphs indicate the fold increase in 
donor OTI numbers in ctrl recipients over LCMV clone 13 infected recipients. 
N=2 per groups, data is representative of seven independent experiments.  Error
bars are SEM.
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functions of donor OTI CD8 T cells transferred to LCMV clone 13 infected 
recipients were also somewhat compromised.  The frequency of donor OTI CD8 
T cells that co-produced IFNγ and TNFα was slightly lower in the chronically 
infected recipients, and IL-2 production was substantially, if not significantly, 
diminished (Fig 21d).  The survival of donor OTI CD8 T cells was also decreased 
in the chronically infected recipients compared to the controls.  The frequency of 
the donor OTI CD8 T cells in the blood of the control mice remained relatively 
stable over 30 days, whereas the frequency declined in the blood of the LCMV 
clone 13 recipients (Fig 21e).  More strikingly, the absolute number of donor OTI 
CD8 T cells was greatly decreased in both lymphoid and non-lymphoid tissues.  
The difference in recovery of donor OTI CD8 T cells ranged from 6-fold (liver and 
bone marrow) to 26-fold (spleen), indicating a systemic decrease rather than 
redistribution of donor OTI CD8 T cells due to differences in migration within the 
two recipient groups (Fig 21e).  Together, these data suggest that, like the direct 
co-infection model, chronic inflammation alone can impact the differentiation of 
CD8 T cell responses.  More specifically, chronic inflammation appears to be 
able to repress memory differentiation, preventing the acquisition of memory 
properties such as CD127 and CD62L expression and IL-2 production. 
 
Chronic inflammation alone does not regulate expression of inhibitory receptors. 
 Along with the repression of memory differentiation, the expression of 
inhibitory receptors is a cardinal feature of functional exhaustion.  In particular, 
the high expression of PD-1 has been associated with many human and murine 
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models of chronic viral infection (14), and of the numerous inhibitory molecules 
upregulated during chronic LCMV infection, PD-1 is one of the most commonly 
expressed by exhausted CD8 T cells (160).  Recent reports have also suggested 
that PD-1 expression can be upregulated by γ chain cytokines (228), some of 
which are elevated during chronic viral infection (data not shown).  To determine 
whether chronic ‘inflammation’ alone could regulate this property of functional 
exhaustion, we examined the donor OTI CD8 T cells for PD-1 expression after 
adoptive transfer to control or LCMV clone 13 infected recipients.  At 2 days post 
adoptive transfer, donor OTI CD8 T cells transferred to both control and 
chronically infected recipients expressed similar levels of PD-1 (Fig 22a).  It 
should be noted that effector and memory CD8 T cells also express PD-1 after 
acute infection (162, 163) though the majority of these cells are PD-1int/lo rather 
than PD-1hi as most exhausted CD8 T cells are (data not shown) (163).  
Inhibitory receptor expression was also not upregulated by chronic inflammation 
over time, as donor OTI CD8 T cells in both control and LCMV clone 13 infected 
recipients retained similar PD-1 expression at d30 post adoptive transfer (Fig 
22b).  Furthermore, the level of PD-1 expression on the donor cells was lower 
than on exhausted CD8 T cells specific for LCMV (Fig 22b).  Thus, while chronic 
inflammation alone seems capable of altering some key memory properties of 
differentiating CD8 T cells, another signal such as antigen may be required to 
regulate other aspects of T cell dysfunction during chronic viral infection, such as 
the high expression of inhibitory receptors.  
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Figure 22.  Chronic inflammation alone does not lead to high PD-1 
expression.  A) PD-1 expression pre- and post-transfer.  PD-1 expression on 
donor OTI CD8 T cells just prior to adoptive transfer to ctrl or LCMV clone 13 
infected recipients (pre-transfer), and two days post-transfer in the blood (ctrl, 
Cl-13).  Error bars are SEM.  Data is representative of seven independent 
experiments.  B) PD-1 expression 1 month post-transfer in the spleen.  Plots are 
gated on total CD8 T cells.  Numbers in plots indicate the percent of donor OTI 
CD8 T cells that are PD-1int/hi.  Histograms are gated on tetramer+ CD8 T cells, 
with the exception of naive.  Naive (shaded histogram) is gated on CD44lo 
CD62Lhi cells in ctrl mice.  Exhausted (dashed) is gated on DbGP33+ CD8 T cells 
in LCMV clone 13 infected recipients.  Ctrl OTI (red) and Cl-13 OTI (black) are 
gated on donor OTI CD8 T cells from ctrl and LCMV clone 13 infected recipients, 
respectively.  Data is representative of seven independent experiments.
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Different types of chronic inflammation can repress memory CD8 T cell 
differentiation. 
 While LCMV clone 13 is a very useful model for different types of chronic 
viral infection, it is possible that the inflammation induced by this pathogen is 
unique in its ability to repress memory differentiation.  To test whether our results 
were specific to LCMV, we also used Toxoplasma gondii (toxo) as another model 
of chronic infection.  While both LCMV and toxo induce inflammation that is 
skewed towards Th1, LCMV is primarily driven by type I interferons (92, 229), 
while toxo induces IL-12 mediated inflammation (230, 231).  The adoptive 
transfer system described previously was used (Fig 21a), but with toxo infected 
Ly5.1+ recipients as our experimental group.  As observed with LCMV clone 13, 
donor OTI CD8 T cells transferred to toxo infected recipients did not appear to 
differentiate into memory CD8 T cells, as the cells remained CD127lo (Fig 23a).  
There was also a drastic difference in the survival of donor OTI CD8 T cells 
between the control and toxo infected groups.  The frequency of donor OTI CD8 
T cells was much lower in toxo infected recipients compared to the controls 
immediately after adoptive transfer, and remained low over 30 days post transfer 
(Fig 23b).  The recovery of donor OTI CD8 T cells from the tissues of toxo 
infected recipients was also significantly lower in the spleen and liver, and a 
similar trend was observed in the lymph nodes, indicating that the decrease in 
donor cell numbers was not simply to due to migration (Fig 23b).  The parallels 
between the LCMV clone 13 model and the toxo model suggest that different 
types of chronic inflammation (i.e. type I interferon driven vs. IL-12 driven) may 
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Figure 23.  Chronic inflammation during toxoplasma infection represses
memory CD8 T cell differentiation.  Experimental design outlined in Fig. 21
was used, but with toxoplasma infected recipients instead of LCMV clone 13 
infected recipients.  A) Phenotype of donor OTI CD8 T cells in ctrl and toxo 
infected recipients in the blood 18 d.p.i..  Plots are gated on total CD8 T cells, 
histograms are gated on donor OTI CD8 T cells.  Numbers in plots indicate the 
percent of total CD8 T cells that are KbSIINFEKL+.  Black numbers in histograms 
show percent of donor OTI population that is CD127hi.  Red numbers show MFI 
of CD127 expression.  B) Number of donor OTI CD8 T cells in ctrl and toxo infected
recipients 1 month post-transfer.  Frequency of donor OTI CD8 T cells was 
determined in the blood at the indicated time points.  Absolute number of donor 
OTI CD8 T cells was measured in each of the indicated tissues.  N=3-4 per group.  
For spleen, *p=0.04, for liver, *p=0.02 by Student’s t-test.  Error bars are SEM.  All 
data are representative of two independent experiments.
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repress memory differentiation, and that there may be factors common to 
different types of chronic infections that can alter memory CD8 T cell 
differentiation.    
 
Established memory CD8 T cells are plastic but less susceptible to chronic 
inflammation than differentiating effector CD8 T cells. 
 Our data thus far indicate that the memory CD8 T cell differentiation 
pathway can be altered by the inflammation present during chronic infections.  It 
is not clear, however, whether the responsiveness of CD8 T cells to their 
environment is maintained throughout the memory phase.  There is evidence that 
tissue microenvironments may be able to dictate the properties of memory CD8 T 
cells (232, 233), and the memory CD8 T cell population continues to differentiate 
long after the initial infection is cleared (64, 135, 137).  To test the plasticity of 
memory CD8 T cells, we examined whether established memory CD8 T cells 
could be influenced by chronic inflammation using our adoptive transfer system.  
5x105 OTI splenocytes were transferred to naïve recipients, which were 
challenged with VSV-OVA.  At approximately one month p.i., memory OTI CD8 T 
cells that were generated were transferred to either control Ly5.1+ recipients or 
Ly5.1+ LCMV clone 13 recipients that had been infected 30 days prior (Fig 24a).  
The transferred memory OTI CD8 T cells were mostly CD127hi, starting to 
upregulate CD62L and were capable of producing IL-2 (Fig 24b).   
At 30 days post transfer, donor OTI CD8 T cells in the control recipients 
retained high CD127 expression and further increased expression of CD62L (Fig 
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Figure 24.  Established memory CD8 T cells are more resistant to alteration
by chronic inflammation than effector CD8 T cells.  A) Schematic of 
experiment.  5x105 OTI splenocytes were adoptively transferred to naive donor 
B6 mice and challenged with VSV-OVA.  One group of recipient Ly5.1+ B6 
recipients was infected with LCMV clone 13 at the same time.  Another ctrl
recipient group was left naive or infected with VSV-OVA or LCMV Arm.  No 
difference was observed between the ctrl groups.  30 d.p.i., CD8 T cells were 
purified from the spleens of donor mice and equal numbers of donor OTI CD8 T
cells were adoptively transferred to Ly5.1+ LCMV clone 13 infected recipients
and Ly5.1+ ctrl recipients.  Donor OTI CD8 T cells were analyzed 1 month post-
transfer.  B) Donor OTI CD8 T cells pre-transfer (30 d.p.i.).   Left and middle
plots are gated on total CD8 T cells.  Numbers in plots indicate the percent of 
donor OTI CD8 T cells that are positive for each marker.  Right plot is gated on 
donor CD8 T cells.  Splenocytes were stimulated with OVA peptide for 5 hrs at
37C.  Number indicates the percent of IFNγ+ cells that  co-produce IL-2.  Data
is representative of three independent experiments.  (Figure continued on next
page.)         
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Figure 24 (cont.)  Established memory CD8 T cells are more resistant to
alteration by chronic inflammation than effector CD8 T cells.  C) Phenotype
of donor OTI CD8 T cells in the spleen 1 month post-transfer.  Plots are gated on
total CD8 T cells, histograms are gated on donor OTI cells.  Numbers in plots 
show percent of total CD8 T cells that are donor OTI.  Numbers in histograms 
indicate the percent of donor OTI that are positive for each marker.  Numbers are 
graphed below.  N=3 per group.  Error bars are SEM.  D) Effector function of donor 
OTI cells.  Splenocytes from recipient mice were stimulated with OVA peptide for 
5 hrs at 37C.  Left plots are gated on total CD8 T cells.  Numbers indicate percent 
of total CD8 T cells that produce IFNγ.  Middle and right plots are gated on donor 
CD8 T cells.  Numbers show the percent of IFNγ+ cells that also produce the 
second indicated cytokine.  Numbers are graphed below.  N=3 per group, error 
bars are SEM.  E) Number of donor OTI CD8 T cells.  Frequency of donor OTI 
CD8 T cells were measured in the blood at the indicated time points.  Absolute 
number of donor OTI CD8 T cells were determined in each tissue.  N=3 per 
group, error bars are SEM.  All data is representative three independent 
experiments.     
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24c).  The majority of donor OTI CD8 T cells transferred to LCMV clone 13 
infected recipients also remained CD127hi, though the level of expression was 
lower than in the control recipients (Fig 24c).  The upregulation of CD62L by a 
memory CD8 T cell population is an indicator of the transition from effector to 
central memory (68, 135, 143, 144), and though a subset of donor OTI CD8 T 
cells maintained high CD62L expression in the chronically infected recipients, no 
further upregulation was observed (Fig 24b,c).  Other molecules associated with 
memory ‘maturation’, including CD27 and CXCR3, were also not as highly 
expressed on donor OTI CD8 T cells in chronically infected recipients as 
compared to controls (data not shown).  While TNFα and IFNγ co-production by 
the donor OTI CD8 T cells did not appear to be compromised, IL-2 and IFNγ co-
production did not increase in the LCMV clone 13 infected recipients as it did in 
the controls (Fig 24d).  Unlike donor effector OTI CD8 T cells, the survival of 
donor memory OTI CD8 T cells did not appear to be greatly affected by chronic 
inflammation.  The frequency of donor OTI CD8 T cells in the blood remained 
similar and stable over the course of a month post transfer, and the absolute 
number of donor OTI CD8 T cells did not differ greatly between control and 
chronically infected groups in both lymphoid and non-lymphoid tissues (Fig 24e).  
Thus, our data indicate that while established memory CD8 T cells do not appear 
to be actively altered by low levels of persistent inflammation, the transition from 
effector memory to central memory seems to be prevented or delayed by 
prolonged inflammation. 
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Extent of memory CD8 T cell differentiation alteration is determined by severity of 
chronic inflammation and differentiation state of the cell. 
 Thus far, our data indicate that the transition from effector to memory CD8 
T cell is highly susceptible to alteration by chronic inflammation, while 
established memory CD8 T cells retain their memory properties but do not 
appear to transition from effector to central memory.  However, the transferred 
effector and memory OTI CD8 T cells were likely exposed to different amounts of 
inflammation.  During LCMV clone 13 infection, more virus is present at the early 
d8 time point than at d30 p.i., at which point the virus is beginning to be cleared 
from tissues such as the spleen and liver (89).  Furthermore, the CD8 T cell 
response, which peaks at ~d8 p.i., is more functional at this early time point than 
at the later d30 time point (89).  Thus, due to the differences in pathogen burden 
and effector functions of the immune response, it is likely that both the severity 
and composition of the inflammation present is different at early (d8) and late 
(d30) stages of the infection.  In order to determine whether our observations 
were due to the differentiation stage of the donor OTI CD8 T cells or due to the 
level of chronic inflammation, we adoptively transferred effector OTI CD8 T cells 
(d8) into recipient mice 30 days post infection with LCMV clone 13 (low 
inflammation) (Fig 25a).  We also transferred memory OTI CD8 T cells (d30) into 
recipient mice 8 days post infection with LCMV clone 13 (high inflammation) (Fig 
26a). 
 Donor effector OTI CD8 T cells that were transferred into d30 LCMV clone 
13 infected recipients unexpectedly did not display a sharp decrease in CD127 
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Figure 25.  Low levels of chronic inflammation have a less profound impact on effector CD8 T cells differentiating
into memory CD8 T cells.  A) Schematic of experiment.  Experimental design from Fig 21a and 24a was used, except
d8 effector OTI CD8 T cells were transferred into recipient mice infected with LCMV clone 13 30 days prior (d8 to 30).
Donor OTI CD8 T cells were analyzed one month post-transfer.  B) Phenotype of donor OTI CD8 T cells in the spleen.
Plots are gated on total CD8 T cells, histograms are gated on donor OTI CD8 T cells.  Numbers in histograms show 
percent of donor OTI CD8 T cells that are positive for each marker.  Numbers are graphed below.  For CD127, **p=0.002 
by Student’s t-test.  N=4 per group, error bars are SEM.  C) Effector function of donor OTI CD8 T cells.  Splenocytes from 
recipient mice were stimulated with OVA peptide for 5 hrs at 37C.  Graphs show percent of IFNγ+ that also produce 
the second indicated cytokine.  For TNFα *p=0.05, for IL-2 *p=0.02 by Student’s t-test.  N=4 per group, error bars are SEM.   
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expression 30 days post transfer. (Fig 25b).  While significant, the fold difference 
in CD127 expression between the control and chronically infected recipients was 
not as great as observed during the adoptive transfer to d8 LCMV clone 13 
infected recipients (high inflammation) (Fig 21c, 27).  There was also little 
difference in CD62L expression between the two groups (Fig 25b). Cytokine 
production, however, was still compromised by low levels of inflammation, and 
donor OTI CD8 T cells from the d30 LCMV clone 13 infected recipients had 
significantly less TNFα and IL-2 production as compared to the controls (Fig 
25c).  It should be noted that this data is preliminary, as the experiment has only 
been performed once.  When memory OTI CD8 T cells were transferred to d8 
LCMV clone 13 infected recipients (high inflammation), CD127 expression 
decreased significantly, and CD62L expression did not increase 30 days post-
transfer (Fig 26b).  Effector functions, however did appear to be greatly 
compromised.  Co-production of IFNγ with either TNFα or IL-2 by the donor OTI 
CD8 T cells was only slightly decreased in the chronically infected recipients (Fig 
26c).  These data suggest certain memory CD8 T cell properties, such as high 
CD127 expression and upregulation of CD62L, are more susceptible to the 
effects of chronic inflammation in differentiating effector CD8 T cells than in 
established memory CD8 T cells (Fig 27).  Together, our data indicate that CD8 
T cell differentiation can be impacted by both high and low levels of chronic 
inflammation at all stages of the immune response, including the effector to 
memory transition as well as the effector memory to central memory transition.   
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Figure 26.  Memory CD8 T cells are more resistant than effector CD8 T cells to high levels of chronic inflammation.
A) Schematic of experiment.  Experimental design from Fig 21a and 24a were used, except memory OTI CD8 T cells were
transferred to recipients at d8 post-LCMV clone 13 infection (d30 to 8).  Donor OTI CD8 T cells were analyzed 1 month 
post-transfer.  B) Phenotype of donor OTI CD8 T cells in the spleen.  Plots are gated on total CD8 T cells, histograms are
gated on donor OTI.  Numbers in histograms show percent of donor OTI that are positive for each marker.  Numbers are 
graphed below.  For CD127, ***p<0.0001, for CD62L *p=0.001.  N=8, error bars are SEM.  C) Effector function of donor
OTI CD8 T cells.  Splenocytes from recipient mice were stimulated with OVA peptide for 5 hrs at 37C.  Graphs represent
percent of IFNγ+ cells that also produce the second indicated cyokine.  N=4, error bars are SEM.  All data is representative
of two independent experiments.  
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Figure 27.  Summary of CD127 and CD62L expression.  Graphs show fold difference
in marker expression of donor OTI CD8 T cells from ctrl recipients over LCMV clone 13
infected recipients.  Top graph shows all experiments performed with donor effector
OTI CD8 T cells (d8) transferred to early (d8) or late (d30) time points post-LCMV clone 
13 infection of recipients.  Bottom graph shows all experiments performed with donor 
memory OTI CD8 T cells (d30) transferred to early (d8) or late (d30) time points post-
LCMV clone 13 infection of recipients.  Data is representative of 1-7 independent 
experiments.
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Secondary responses of memory CD8 T cells may be compromised by exposure 
to chronic inflammation. 
 Our results thus far indicate that chronic inflammation appears capable of 
repressing memory CD8 T cell differentiation.  As the ability to mount a rapid, 
potent secondary response is a critical property of functional memory CD8 T cells 
(73), we examined whether exposure to chronic inflammation could affect this 
feature.  In order to assess the intrinsic potential of the donor CD8 T cells to 
respond to a secondary challenge, a second round of adoptive transfers were 
performed (Fig 28a).  In brief, experiments were carried out as described in Fig 
21a, 24a, 25a and 26a.  For each experiment, after a month post transfer, equal 
numbers of OTI CD8 T cells from the spleens of either LCMV clone 13 infected 
recipients or control recipients were transferred to new, naïve, Ly5.1+ recipients 
after CD8 purification by magnetic beads (Fig 28a).  These new Ly5.1+ recipients 
were then challenged with LM-OVA (Fig 28a).  Five to six days later, the 
secondary OTI CD8 T cell responses were analyzed and bacterial burden was 
measured.      
 Regardless of the differentiation state of OTI CD8 T cells at the time of the 
first adoptive transfer or the level of chronic inflammation, OTI CD8 T cells that 
had been transferred from chronically infected groups did not accumulate as 
much after secondary challenge as those that had been transferred from the 
control groups (Fig 28b).  Compared to the controls, the difference in magnitude 
of secondary responses was greatest for effector donor OTI CD8 T cells that had 
differentiated in the presence of high inflammation (d8 to 8) (Fig 28b).  The 
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Figure 28. Exposure to chronic inflammation compromises secondary responses.  A) Schematic of experiment.  
1 month after the transfers described in Fig 21a (d8 to 8), 24a (d30 to 30), 25a (d8 to 30), and 26a (d30 to 8), equal 
numbers of donor OTI cells from either ctrl or LCMV clone 13 infected recipients were transferred to new naive Ly5.1+ 
B6 recipients.  The new recipients were challenged with LM-OVA, and secondary responses were measured 5-6 days 
post-challenge. (Figure continued on next page.)  
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Figure 28 (cont.) Exposure to chronic inflammation compromises 
secondary responses.  B) Accumulation of donor OTI CD8 T cells after in the 
spleen. Top row shows donor OTI CD8 T cells that rested in the ctrl group for 1
month, bottom row shows donor OTI CD8 T cells that rested in the LCMV clone 
13 infected group for 1 month prior to secondary challenge.  All plots are gated on 
total CD8 T cells.  Numbers in plots show percent of total CD8 T cells that are
donor OTI.  Absolute number of donor OTI CD8 T cells are graphed below. 
Numbers above each graph show fold difference in accumulation between donor
OTI CD8 T cells from ctrl vs. LCMV clone 13 infected groups.  Data is 
represenative of 1-2 independent experiments.  C) Bacterial burden after 
secondary challenge.  Left graph shows secondary challenge after transfer of 
memory OTI to d30 LCMV clone 13 infected recipients, middle and right graphs
show secondary challenge after transfer of memory OTI to d8 LCMV clone 13
infected recipient.  Bacterial burden in each indicated tissue was measured by 
colony growth on BHI agar at 37C for 24 hrs.
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difference was minimal for memory OTI CD8 T cells that had differentiated in a 
situation of low inflammation (d30 to 30) (Fig 28b).  However, preliminary data 
indicate that these memory OTI CD8 T cells (d30 to 30) were not as efficient in 
controlling bacterial burden upon secondary challenge (Fig 28c).  Memory CD8 T 
cells that differentiated in a situation of high inflammation (d30 to 8) also 
appeared to be less protective, although it is difficult to compare the impact that 
exposure to low vs high inflammation may have had on protective immunity (Fig 
28c).  Thus, our data suggest that memory differentiation in the presence of 
chronic inflammation alone can lead to the development of memory CD8 T cells 
that may provide suboptimal protection. 
 
 
Discussion 
 In this study, we describe a role for inflammation in the dysregulation of 
memory CD8 T cell differentiation during chronic infection.  By using an adoptive 
transfer system with OTI TCR transgenic CD8 T cells that do not recognize any 
LCMV epitopes, we find that chronic ‘inflammation’ alone prevented the 
acquisition of several key memory properties during the effector to memory 
transition, including the upregulation of CD127 and CD62L, and high IL-2 
production, but did not lead to upregulation of inhibitory receptor expression.  The 
conversion of established TEM to TCM could also be prevented by persistent 
inflammation, although the impact was not as profound as on the effector to 
memory transition.  Both the activation state of the CD8 T cell (effector or TEM) 
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and the level of inflammation (early or late during chronic infection) were 
important in determining the severity of dysfunction.  Regardless of the situation, 
the cellular changes that occurred in the donor CD8 T cells resulted in impaired 
secondary responses. 
 During chronic viral infections, CD8 T cells can become functionally 
exhausted and undergo altered memory differentiation.  Although these two 
major defects are often observed together (14), there are certain models of 
chronic viral infection, such as γHV, where altered memory differentiation is 
uncoupled from loss of effector function and observed alone in dysfunctional CD8 
T cells (179, 234).  This raises the question as to whether different factors 
regulate distinct aspects of T cell dysfunction during chronic infection.  Our data 
suggest that chronic inflammation alone may regulate altered memory CD8 T cell 
differentiation, and that additional signals are required to mediate the loss of 
effector function (89, 90) and upregulation of inhibitory receptors (23) that are 
characteristic of functional exhaustion.  While expression of memory markers 
such as CD127 is downregulated by chronic inflammation, it is not yet clear 
whether this has any functional consequences for the cell.  The expression of 
CD127 can be regulated by both IL-7 (235, 236) and TCR stimulation (63). 
However, in human T cells, TCR signaling causes a more ‘permanent’ 
downregulation of CD127 than IL-7 signaling (237).  Furthermore, forced 
expression of CD127 does not impart any selective advantage in the 
differentiation of memory CD8 T cells after acute infection (95), suggesting that 
expression of this marker does not ensure memory differentiation.  Conversely, 
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this suggests that loss of CD127 may not necessarily deter a precursor cell from 
acquiring memory properties, such as the ability to use IL-7 for homeostasis.  In 
an LCMV model of chronic viral infection, as this work and other studies have 
shown, exhausted virus-specific CD8 T cells do not utilize IL-7 and IL-15 
efficiently, both in vitro and in vivo (Chapter 3) (174, 180).  Exhausted virus-
specific CD8 T cells appear to become ‘addicted’ to antigen (Chapter 3), and it is 
not yet clear whether chronic stimulation through the TCR as well as prolonged 
inflammation are necessary to limit reliance on homeostatic cytokines and induce 
antigenic ‘addiction’. In the future, it will be important to determine whether 
defective memory differentiation regulated by chronic inflammation alone is 
comparable to defective memory differentiation of exhausted CD8 T cells that 
have been stimulated by both persistent inflammation and antigen. 
 Effector cells and TEM are both populations that evolve over time, as 
memory precursors differentiate to long-lived memory and TEM convert to TCM 
(66).  Adoptive transfers performed with effector CD8 T cells and effector 
memory CD8 T cells indicated that effector memory CD8 T cells, while plastic, 
were less affected by chronic inflammation than effector CD8 T cells, regardless 
of the severity of inflammation.  This implies a cell-intrinsic resistance to 
alteration.  One possibility is that memory CD8 T cells do not express or 
downregulate expression of the receptors that are required to recognize input 
from the chronic inflammatory environment.  Another possibility is that gene 
expression patterns in memory CD8 T cells are more firmly imprinted than in 
effector CD8 T cells.  Differentiation and cell fate decisions are accompanied by 
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epigenetic control and chromatin remodeling in numerous different cell types.  
Epigenetic marks are used extensively in multiple different cells during 
development (238, 239).  Chromatin remodeling can also occur in more mature 
cell types, including CD4 T cells within the Th1/Th2 paradigm (37).  Epigenetic 
regulation leads to heritable changes in gene expression and can reduce (or 
increase) the accessibility to certain genes by cell-extrinsic signals (37, 238, 
239).  Memory CD8 T cells acquire histone modifications that aid their function 
(115), and rapid production of IL-2 is mediated by DNA demethylation (114).  
These epigenetic markers of differentiation could potentially render memory CD8 
T cells partially refractory to the effects of chronic inflammation.  Still, memory 
CD8 T cells are not completely unresponsive to persistent inflammation, as 
conversion from TEM to TCM is halted or delayed.  Thus, the question remains as 
to whether memory CD8 T cells generated after an acute infection ever reach a 
terminally differentiated, non-plastic state.  It will be important to determine 
whether memory properties, such as the ability to mount robust secondary 
responses, always remain open to the influence of inflammatory signals, as this 
could have critical implications for the function of previously established memory 
populations in patients infected with pathogenic chronic infections.   
 The specific signals present in chronic inflammation that alter memory 
differentiation have not yet been elucidated. Multiple factors that are generated 
during chronic infection have been shown to be critical in determining the 
functionality of T cells, including IL-10 (183, 184) and IL-21 (186-188).  After an 
acute infection, a ‘third signal’, such as IL-12 or type I IFN, is required for proper 
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activation and subsequent memory differentiation (116, 117).  Other non-cytokine 
signaling pathways, such as those mediated by MyD88, are also important for 
the proper differentiation (29).  It is not yet clear whether chronic inflammation is 
actively altering memory differentiation by the presence of a particular signal(s), 
or whether memory differentiation is not occurring because of the lack of a 
particular signal in the chronic inflammatory environment. One possible factor 
that may be lacking is CD4 help.  CD4 responses, like CD8 responses, are 
impaired during chronic viral infections, including LCMV (156, 240, 241), HIV 
(161, 242-244), and HCV (245, 246).  CD4 T cell exhaustion could potentially 
lead to insufficient CD4 help for CD8 T cells during chronic viral infection, which 
could contribute to memory defects.  Our data shows that the memory 
differentiation defects induced by chronic inflammation are not unique to LCMV 
clone 13 infection, as the IL-12-driven inflammatory environment of toxoplasma 
also leads to similar defects (i.e. CD127 expression, survival) in memory 
differentiation.  This indicates that there may be similarities across multiple 
different types of chronic infection that induce comparable dysfunction in CD8 T 
cells, and may be an efficient method of determining the signals are important in 
the regulation of memory differentiation.  In the future, it will be interesting to 
determine whether other types of chronic inflammation, including Th2- and Th17-
driven inflammation, as well as inflammation resulting from autoimmune disease 
or cancer, also result in functional exhaustion and altered memory differentiation. 
 In summary, we have identified a role for persistent inflammation in the 
regulation of memory differentiation during chronic viral infection.  Effector CD8 T 
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cells undergoing memory differentiation do not acquire key memory properties, 
such as the high expression of homeostatic cytokine receptors and ability to 
mount robust secondary responses to a challenge.  The transition from TEM to 
TCM is also prevented or delayed by prolonged inflammation.  The differentiation 
state of the CTL as well as the severity of inflammation both determined the 
extent of dysfunction.  Furthermore, our observations were not limited to chronic 
LCMV infection, as the inflammatory environment of toxoplasma also led to 
defects in memory differentiation, indicating that this may be a common feature 
of different types of chronic inflammation.    
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Chapter 5 
Discussion 
 
Overview of results. 
 Chronic infections are a severe burden on society, limiting quality of life, 
threatening public health and incurring a great cost for many of the world’s 
economies.  Hundreds of millions of people around the world are afflicted with 
one or more chronic viral infections such as HIV (7), HCV and HBV (8), as well 
as bacterial infections such as TB (247) and parasitic infections such as malaria 
(248).  While we have made great strides in understanding the pathogenesis of 
these infections, we still do not have sufficient knowledge of the impact these 
infections have on the immune system in order to restore natural clearance of the 
pathogen.  CD8 T cell exhaustion is a feature of many different chronic viral 
infections (14), and likely contributes to the poor control of these diseases.  While 
functional exhaustion has been observed in many different infections and model 
systems (14), we still do not fully understand how differentiation of exhausted 
CD8 T cells is regulated or what the underlying molecular mechanisms are. The 
work in this thesis attempts to further our understanding of functional exhaustion 
by addressing three different aspects: transcriptional regulation, homeostatic 
mechanisms and the regulation of the differentiation process by host-pathogen 
interactions. 
119
While functional exhaustion is known to be a common feature of many 
chronic infections, the molecular mechanisms underlying this state have not been 
elucidated.  Gene expression studies suggest that functional exhaustion is a 
differentiation process that is guided by a unique transcriptional program (158).  
The first chapter focuses on the transcriptional repressor Blimp-1 and the role 
that it plays in regulating functional exhaustion.  We found that Blimp-1 is 
upregulated in exhausted antigen-specific CD8 T cells as compared to naïve, 
effector and memory CD8 T cells generated after acute infection, and that Blimp-
1 expression correlated with severity of dysfunction.  Conditional deletion of 
Blimp-1 led to decreased expression of inhibitory receptors and upregulation of 
memory markers such as CD127 and CD62L.  However, by controlling the 
number of alleles that were deleted, we found that some Blimp-1 expression was 
required for the acquisition and/or maintenance of effector function, especially 
cytotoxicity.  The temporal aspect of Blimp-1 expression also appeared to be 
crucial, as CD8 T cells lacking Blimp-1 prior to activation had higher viral titers 
than wt mice earlier during chronic infection.  Thus, our study suggested that 
Blimp-1 may be acting as a molecular rheostat, regulating effector function and 
memory differentiation at low or intermediate levels, while promoting functional 
exhaustion at high levels.  While we describe an important role for Blimp-1, it is 
likely that other transcription factors also play a critical role in the regulation of 
functional exhaustion.  Insight into the actions of Blimp-1 as well as other 
transcription factors in promoting (or repressing) T cell dysfunction could lead to 
new, potential therapeutic targets in the treatment of chronic infections. 
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Aside from the loss of effector function and upregulation of inhibitory 
receptors, dysfunctional CD8 T cells also follow a path of altered memory 
differentiation.  Unlike memory CD8 T cells that differentiate after acute infection, 
exhausted CD8 T cells express low levels of CD127 and CD122, and they do not 
use the cytokines IL-7 and IL-15 for their homeostasis.  Despite this, however, 
they persist long-term in chronically infected hosts.  In the third chapter we 
address this apparent paradox by performing adoptive transfers using a variant 
clone 13 strain that does not present the GP33 peptide.  With this variant virus, 
we found that rather than requiring a cytokine, growth factor or some unknown 
cell-cell contact, exhausted CD8 T cells require virus-derived antigen for their 
maintenance.  Furthermore, dysfunctional antigen-specific CD8 T cells also 
undergo a rapid, antigen-driven division that is distinct from the slow, steady, 
cytokine-driven homeostatic proliferation that is characteristic of memory CD8 T 
cells.  It is interesting to note that the features associated with functional 
exhaustion, such as loss of effector function and high amounts of inhibitory 
receptors, become less severe after the control of viremia (155).  However, the 
memory defects of these dysfunctional CD8 T cells remain after virus is 
controlled (174), though it is not known how long these defects persist.  HAART 
treatment of HIV infected patients can lead to a sharp decrease in viral load, 
which could compromise the survival signal that HIV-specific CD8 T cells may 
require (249, 250).  It will be important to determine whether any sort of 
protective immunity can be maintained in after the maintenance signal for 
exhausted antigen-specific CD8 T cell population is diminished or removed. 
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 While the functional exhaustion and altered memory differentiation often 
occur simultaneously during chronic viral infection, there are infection models, 
such as γHV, in which these two states can present separately (179, 234).  This 
suggests that different features of T cell dysfunction may be regulated by distinct 
signals.  Furthermore, co-infections involving pathogens that are not overtly 
immunosuppressive may repress immune responses to heterologous infections, 
suggesting that signals other than persistent antigen may be playing a role (220-
224).  The extrinsic signals that regulate the differentiation of exhausted CD8 T 
cells are not well known, and in the Chapter 4, we focus on the role of chronic 
inflammation in regulating T cell dysfunction.  We find that inflammation alone 
leads to the repression of memory differentiation, but does not lead to the 
upregulation of inhibitory receptor expression.  The effector to memory transition 
was more sensitive to alteration by chronic ‘inflammation’ than the TEM to TCM 
transition, and inflammation present at early time points (d8) after infection 
appeared to have a more severe impact on differentiation than the inflammatory 
environment at later time points (d30).  Furthermore, memory repression induced 
by persistent inflammation was not limited to our model system of chronic 
infection, as the inflammatory environment of chronic toxoplasma infection also 
led to a similar results.  In summary, chronic inflammation leads to repression of 
memory differentiation, but other signals, such as persistent antigen, may be 
necessary to induce the loss of effector function and upregulation of inhibitory 
receptors associated with functional exhaustion.  Our work could have important 
implications for the development of cellular responses in the case of co-
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infections.  Chronic infections could not only impact the differentiation of new 
memory populations after infection or vaccination, but they could also erode 
protective immunity established by prior infections or vaccinations.  A study by 
Puissant-Lubrano et al show that in ART-treated HIV patients, memory 
responses to childhood vaccination against smallpox were lost, but memory was 
maintained against the BCG vaccine, in which antigen persists (251).  While the 
study did not distinguish between a loss of immunity due to ‘inflammation’ and 
direct loss of T cells via HIV infection, it still raises the possibility that protective 
immunity to heterologous infections may be compromised by ongoing chronic 
infections. 
 
Regulation of T cell exhaustion and memory differentiation. 
 After an acute infection, inflammation can affect the antigen-specific CD8 
T cell population by regulating both the size of the clonal burst after activation 
(252) and the differentiation of terminally differentiated effectors vs. memory 
precursors (60).  While antigen load is a strong correlate for the severity of T cell 
dysfunction during chronic viral infection (89) and may directly cause functional 
exhaustion (219), it is not clear how prolonged inflammation impacts the 
regulation of functional exhaustion during chronic viral infection.  Our data from 
Chapter 4 show that inflammation can repress aspects of memory differentiation, 
but other signals such as antigen may be necessary to induce some of the 
hallmarks of functional exhaustion, such as loss of effector function and high 
expression of inhibitory markers.  Thus, in order to generate a functional 
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population of true memory CD8 T cells, rest from both antigen and inflammation 
appear to be necessary.   
The mechanism by which inflammation alters or represses the 
development of memory is not yet clear.  Further work needs to be done to 
determine the specific signals that are regulating this process, although it is 
intriguing that expression of two transcription factors, Tbet and Blimp-1, that play 
an important role in the fate decision between memory precursors and terminally 
differentiated effector CD8 T cells during acute infection can be mediated by 
inflammatory signals.  Tbet expression can be regulated by IL-12 in CD8 T cells 
(60), and the differential expression of Tbet between memory precursors and 
terminally differentiated effector CD8 T cells can be controlled by both strength of 
TCR and severity of inflammation (60, 61).  Likewise, Blimp-1 expression in T 
cells is regulated by cytokine signals such as IL-2 and IL-4 (197, 198), and in B 
cells can be regulated by a variety of factors, including cytokines and TLR 
ligands (253).  Furthermore, we show in Chapter 2 that Blimp-1 plays an 
important role in repressing memory differentiation in exhausted CD8 T cells 
during chronic viral infection (Fig 29).  It will be important to determine whether 
different types of persistent inflammation (i.e. Th2, Th17, cancer 
microenvironments, etc.) can also alter memory CD8 T cell differentiation, and 
whether there are changes to the transcriptional profiles of the antigen-specific 
CD8 T cells that are common to different inflammatory settings.  By using this 
approach, it may be possible to identify common factors within different settings 
of prolonged inflammation that can regulate the expression of certain 
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transcription factors such as Blimp-1, and thus alter memory differentiation. 
Determining the specific signal(s) that may regulate memory CD8 T cell 
differentiation during chronic infection could provide new targets for future 
therapies. 
 
Heterogeneity of the exhausted CD8 T cell population. 
After an acute infection, memory CD8 T cells form a heterogeneous 
population composed of different subsets.  While the lineage relationship 
between the TEM and TCM subsets remains under contention, it is clear that they 
are delineated by cells with differences in phenotype (134, 137), function, such 
as the ability to mount secondary responses and produce IL-2 (135, 140, 142), 
and tissue migration (134, 135, 138)  Another aspect of memory heterogeneity 
comes from a stem cell model of self-renewal (130-132), where only a subset of 
memory CD8 T cells would potentially be recruited to homeostatically proliferate 
and thus maintain the entire population.  The work from Chapter 3 suggests that 
heterogeneity may also exist in the long-term exhausted CD8 T cell population.  
Our data show that the antigen-driven ‘homeostatic’ mechanism of rapid division 
gives rise to two distinct populations – one that divides to antigen, and one that 
does not (Fig 19).  It is possible that all exhausted antigen-specific CD8 T cells 
do eventually divide, but it is also possible that this profile indicates differences in 
the properties of the cells themselves, including proliferative potential or tissue 
migration.  The divided vs. undivided profile may reflect subpopulations that are 
‘tuned’ to antigen differently, and thus possess different proliferative capabilities.  
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During chronic viral infection, immunodominance hierarchies amongst epitope 
specificities can change (89, 217, 218).  With an antigen-driven method of 
maintenance, immunodominance shifts could reflect differences in proliferative 
capacity between TCR specificities.  In addition, as the virus that drives this 
division post-viremia likely resides in tissue reservoirs such as the kidney and 
brain (89), those cells that divide may represent a subpopulation that can more 
efficiently migrate to peripheral tissues, in parallel to the different homing abilities 
of TEM and TCM cells (134, 138).  Subpopulations of cells with different functional 
capacities have been described within the total exhausted CD8 T cell population, 
such as the PD-1hi and PD-1int subsets (163), or those delineated by the 
expression of different numbers of inhibitory receptors (Fig 2 and 8) (160).  It will 
be interesting to examine whether these subsets correlate with cells that are 
capable of dividing upon a ‘homeostatic’ antigen encounter (Fig 29).  In the 
future, it will be important to determine whether this potential heterogeneity 
correlates to differences in the ability to provide protective immunity and how it 
may be manipulated to improve therapeutic strategies.   
 As a whole, exhausted antigen-specific CD8 T cell populations do not 
require IL-7 or IL-15 for their maintenance during chronic viral infections (174, 
178, 179).  However, it is difficult to rule out the possibility that a small subset of 
exhausted CD8 T cells may be able to utilize IL-7 and IL-15 rather than antigen 
for their homeostasis.  In Fig 18, a small population of donor cells persists in the 
absence of cognate antigen up to 10 weeks after adoptive transfer.  In human 
chronic infections such as HIV, HBV, HCV, CMV and EBV, antigen-specific CD8 
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T cells express low levels of IL-7Rα compared to cells specific for influenza or 
RSV (14, 180).  Furthermore, IL-7 and IL-15 signaling appears to be impaired in 
CMV-specific CD8 T cells .  However, treatment of HIV infected patients with IL-7 
leads to a transient increase in cell cycle entry by HIV-specific CD8 T cells (254).  
This suggests that despite low CD127 expression, some HIV-specific CD8 T cells 
were able to respond to IL-7, though not as efficiently as CD8 T cells specific for 
acute infections such as flu (254).  Also, CD127 expression on antigen-specific 
CD8 T cells during chronic LCMV infection can increase over time after the 
control of viremia (data not shown), and prolonged treatment of HIV patients with 
HAART can also lead to the restoration of CD8 T cell populations with high 
CD127 expression (177, 255).  Due to the potential for decreased protective 
immunity with an antigen-based mechanism of homeostasis after treatment of 
infections such as HIV, it will be important to examine whether there are small 
subsets of antigen-specific CD8 T cells that can be maintained by cytokine and 
whether exhausted CD8 T cells can ever regain their ability to use IL-7 and IL-15 
for homeostasis. 
 
Reversal of T cell dysfunction. 
 One of the ultimate goals of studying functional exhaustion is to uncover 
pathways that will permanently restore productive immune responses during 
chronic infections, and thus mediate natural clearance of a pathogen and provide 
optimal protective immunity.  This goal relies on the assumption that functional 
exhaustion can be reversed, and that the state of T cell dysfunction is not a 
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terminally differentiated one. Considerable evidence suggests that manipulation 
of multiple pathways, including inhibitory receptors (159-162, 171, 256) and 
cytokines (183, 184), can lead to the ‘revival’ of established exhausted CD8 T 
cells at late time points during chronic viral infection.  It is not known, however, 
whether the ‘revival’ of dysfunctional T cells is transient or permanent.  Simply 
resting established, exhausted CD8 T cells (post d15 p.i.) from antigen and 
inflammation is not sufficient to restore proper function (S. Blackburn data not 
shown) (174).  However, data from our lab show that removing antigen-specific 
CD8 T cells from a chronically infected environment at earlier time points (d8 p.i.) 
could rescue the cells from becoming functionally exhausted (S. Blackburn data 
not shown).  Also, only early HAART treatment of HIV patients seems to be 
effective at establishing of CD127hi HIV-specific CD8 T cells (177).   Together, 
the data suggests that functional exhaustion is progressive, and that it may 
become more ‘permanent’ or more difficult to reverse over time.  One possible 
reason for this may be that gradual changes in gene expression occur as 
exhausted CD8 T cells progress in their differentiation (158).  In many other cell 
types, chromatin remodeling plays a key role in limiting the plasticity of a 
particular lineage, whether during development of hematopoeisis (239) or within 
the Th1/Th2 paradigm (37).  As shown in Chapter 2, while expression of the 
transcriptional repressor Blimp-1 in effector CD8 T cells (d8 p.i.) is comparable 
between acute and chronic infection, by d15 p.i. expression during chronic 
infection is much higher than during acute infection (Fig 1).  This sharp 
upregulation correlates with the onset of other markers of functional exhaustion, 
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Figure 28.  Progression of functional exhaustion and population 
heterogeneity during chronic viral infection.  Model of data.  Upon chronic 
infection, naive CD8 T cells expand into a pool of effector CD8 T cells that still 
have the capacity to differentiate into functional memory CD8 T cells if rested 
from antigen and inflammation.  After the effector phase persistent antigen and 
inflammation regulate changes in the gene expression pattern of antigen-specific 
CD8 T cells, including the upregulaton of Blimp-1, as well as the high expression 
of inhibitory receptors.  Inflammation alone also prevents memory differentiation
through an unknown mechanism.  By altering the transcriptional and epigenetic 
landscape, the functionally exhausted fate may become ‘imprinted’ into virus-
specific CD8 T cells, rendering them resistant to memory differentiation without 
extrinsic manipulation (i.e. IL-10/IL-10R or PD-1/PD-L blockades).  
Heterogeneity in the exhausted CD8 T cell pool leads to a subpopulation of virus-
specific CD8 T cells that undergoes rapid, antigen-driven proliferation during the 
maintenance phase and a subpopulation that does not.  It is unclear whether the 
‘undivided’ subset is capable of eventually dividing, or whether it dies.  The model 
above assumes that those cells that are more exhausted will compose the 
population that is ‘undivided’.  It is also unclear whether a very small population of 
cytokine-dependent memory CD8 T cells is generated during chronic viral infection.
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such as the high expression of inhibitory receptors (158, 162).  Blimp-1 is known 
to exert its repressive role by epigenetic modification through the recruitment of 
co-repressors (257), HDACs (258) and methyltransferases (259, 260).  Thus, it is 
possible that the accumulation of effector and memory defects as well as the 
‘imprinting’ of the exhausted cell fate during chronic viral infection may occur 
through chromatin remodeling mediated by differential expression of transcription 
factors such as Blimp-1 (Fig 29).  It will be important to determine whether 
modification of Blimp-1 expression or other transcription factors after onset of 
exhaustion can lead to a lasting reversal of the T cell dysfunction that is present 
during chronic viral infection.  It will also be important to determine whether 
current methods to improve exhausted CD8 T cell function, such as blockade of 
the PD-1/PD-L pathway which leads to selective expansion rather than 
redifferentiation (163), can induce molecular changes that lead to a permanently 
improved population of antigen-specific CD8 T cells. 
 
 In sum, the work in this thesis has attempted to elucidate different 
pathways by which functional exhaustion is regulated during chronic viral 
infection, and to further our knowledge of the biology of these cells.  We hope 
that by understanding how cell-extrinsic and –intrinsic factors regulate the 
process, we can provide new, potential therapeutic targets and design strategies 
that can address different aspects of T cell dysfunction.  Also, by understanding 
the behavior of functionally exhausted CD8 T cells, we can better manipulate 
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them in order to lead to a productive immune response that will ultimately control 
infection and provide optimal protective immunity. 
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